Page last updated: 2024-10-16

methane and Neoplasms

methane has been researched along with Neoplasms in 334 studies

Methane: The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
methane : A one-carbon compound in which the carbon is attached by single bonds to four hydrogen atoms. It is a colourless, odourless, non-toxic but flammable gas (b.p. -161degreeC).

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Age, APACHE score at ICU admission, neurological disease, sepsis and duration of mechanical ventilation were all independent risk factors for the development of delirium in ICU patients."4.40Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023)
"Conventional cancer treatments no longer meet the needs of the health field due to the high rate of mutations and epigenetic factors that have caused drug resistance in tumor cells."3.01Multifunctional Carbon-Based Nanoparticles: Theranostic Applications in Cancer Therapy and Diagnosis. ( Hosseini, SM; Mohammadnejad, J; Najafi-Taher, R; Ramakrishna, S; Tanhaei, M; Zadeh, ZB, 2023)
"An essential aspect of successful cancer diagnosis is the identification of malignant tumors during the early stages of development, as this can significantly diminish patient mortality rates and increase their chances of survival."3.01CNT and Graphene-Based Transistor Biosensors for Cancer Detection: A Review. ( Hussain, CM; Sengupta, J, 2023)
"Cancer is still a leading cause of deaths worldwide, especially due to those cases diagnosed at late stages with metastases that are still considered untreatable and are managed in such a way that a lengthy chronic state is achieved."3.01Nanoparticles in Medicine: Current Status in Cancer Treatment. ( Agaj, A; Bulog, A; Čolić, M; Kraljević Pavelić, S; Pavelić, K; Rojnić, B; Trivanović, D, 2023)
"Combining siRNA and anticancer drugs can give synergistic effects in cancer cells, making them a significant gene-modification tool in cancer therapy."2.82Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy. ( Ali, MS; Pogu, SV; Rengan, AK; Thanekar, AM; Yadav, DN, 2022)
"There is an emerging class of cancer therapeutics engineered to control the release of a drug via enzymatic degradation."2.82Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview. ( Kapalatiya, H; Madav, Y; Tambe, VS; Wairkar, S, 2022)
"Cancer is one of the leading causes of death worldwide."2.82Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer. ( Hegde, N; Juvale, K; Kalave, S, 2022)
"Gynecologic cancers are one of the main health concerns of women throughout the world, and the early diagnosis and effective therapy of gynecologic cancers will be particularly important for the survival of female patients."2.82The Application of Carbon Nanomaterials in Sensing, Imaging, Drug Delivery and Therapy for Gynecologic Cancers: An Overview. ( Hu, J; Li, C; Xiao, C; Zhu, L, 2022)
"In cancer patients with hypersplenism-related thrombocytopenia, PSAE is a safe intervention that effects a durable elevation in platelet counts across a range of malignancies and following the re-initiation of chemotherapy."2.73 ( Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I, 2007)
"CNTs have acted as carriers of anticancer molecules (including docetaxel (DTX), doxorubicin (DOX), methotrexate (MTX), paclitaxel (PTX), and gemcitabine (GEM)), anti-inflammatory drugs, osteogenic dexamethasone (DEX) steroids, etc."2.72Carbon Nanotubes: Smart Drug/Gene Delivery Carriers. ( Ahmadi, S; Bagherzadeh, M; Ghanbari, M; Ghasemi, A; Hamblin, MR; Karimi, M; Mostafavi, E; Rabiee, N; Webster, TJ; Zare, H, 2021)
"As a result of the difficulties of cancer detection and its treatment, the survival rate of patients is unclear."2.72Biosensors and nanotechnology for cancer diagnosis (lung and bronchus, breast, prostate, and colon): a systematic review. ( Abniki, M; Bakhtiari, A; Bazli, L; Esmaeilkhanian, A; Irani, M; Jafari Rad, A; Moghanian, A; Niazvand, F; Sharifianjazi, F, 2021)
"Cancer is one of the most serious health concerns in the 21st century whose prevalence is beyond boundaries and can affect any organ of the human body."2.72Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy. ( Bhatia, R; Narang, RK; Rawal, RK; Sharma, A, 2021)
"Specific targeting of anticancer drugs such as cisplatin, doxorubicin, taxol, gemcitabine, and methotrexate, and delivery of small interfering RNA, micro-RNA, as well as plasmid DNA have been successfully assisted using CNTs."2.66Reassessment of Therapeutic Applications of Carbon Nanotubes: A Majestic and Futuristic Drug Carrier. ( Ahsan, A; Ahsan, W; Javed, S; Kohli, K; Mangla, B, 2020)
"Targeted cancer nanotheranostics have been included for understating tumor micro-environment or cell-specific targeting approach employed."2.66Nanotheranostics for Cancer Therapy and Detection: State of the Art. ( Kenwat, R; Maiti, S; Paliwal, R; Paliwal, SR, 2020)
"The level of ER stress is higher in cancer cells, indicating that such cells are already struggling to survive."2.66Endoplasmic Reticulum Stress Provocation by Different Nanoparticles: An Innovative Approach to Manage the Cancer and Other Common Diseases. ( Allemailem, KS; Almatroodi, SA; Almatroudi, A; Alsahli, MA; Khan, AA; Mahzari, A; Rahmani, AH, 2020)
"Cancer is a major global health problem with large therapeutic challenges."2.61Silver carbene complexes: An emerging class of anticancer agents. ( Balusu, R; Björkling, F; Kankala, S; Taylor, MK; Thota, N; Vadde, R, 2019)
"Artemisinin shows anticancer activity in leukemia, hepatocellular carcinoma, colorectal and breast cancer cell lines."2.61Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment. ( Khair, RR; Kumar, MS; Peters, GJ; Yadav, TT; Yergeri, MC, 2019)
"Inflammation, fibrosis, and malignancy are complex pathological processes that, in summation, underlie a major portion of human disease."2.61Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes. ( Dong, J; Ma, Q, 2019)
"In 2015, cancer was the cause of almost 22% of deaths worldwide."2.58Carbon Nanotube as a Tool for Fighting Cancer. ( Comparetti, EJ; Kaneno, R; Pedrosa, VA, 2018)
"Currently cancer treatment is in large part non-specific with respect to treatment."2.58Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes. ( Leblanc, RM; Pardo, J; Peng, Z, 2018)
"In this context, cancer has become one of the most deadly diseases around the world, and despite many advances in theranostics techniques the treatment of cancer still remains an important problem."2.55Recent advances in carbon based nanosystems for cancer theranostics. ( Augustine, S; Das, A; Malhotra, BD; Sharma, M; Singh, J; Srivastava, M, 2017)
"In the case of cancer therapy, the studies are categorized in two main classes based on the conducted therapy strategies, including targeted drug delivery systems (DDS), and thermal ablation."2.55Carbon nanotubes: A review of novel strategies for cancer diagnosis and treatment. ( Golbabaie, A; Kasaeian, A; Sheikhpour, M, 2017)
" Nanocarriers improve the bioavailability and therapeutic efficiency of antitumor drugs, while providing preferential accumulation at the target site."2.55Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. ( Aman, W; Din, FU; Mustapha, O; Qureshi, OS; Shafique, S; Ullah, I; Zeb, A, 2017)
"Current treatments for cancer and the central nervous system diseases are limited, partly due to the difficulties posed by the insolubility, poor distribution of drugs among cells and lack of selectivity of drugs, the inability of drugs to cross cellular barriers and blood brain barrier (BBB)."2.55Carbon nanotubes-based drug delivery to cancer and brain. ( Guo, Q; Li, YY; Shen, XT; Xu, SQ, 2017)
"Chemotherapy is still one of the main cancer therapy treatments, but the curative effect of chemotherapy is relatively low, as such the development of a new cancer treatment is highly desirable."2.55Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy. ( Chen, B; Liu, Z; Tang, H; Zhang, J, 2017)
" Towards prospective safe clinical applications, the main properties that were adopted to enhance the biocompatibility of SWCNTs were highlighted."2.53SWCNTs as novel theranostic nanocarriers for cancer diagnosis and therapy: towards safe translation to the clinics. ( Al Faraj, A, 2016)
"It can be applied to design cancer medicines with improved therapeutic indices."2.52Carbon Nanomaterials for Drug Delivery and Cancer Therapy. ( Chakrabarti, M; Kiseleva, R; Ray, SK; Vertegel, A, 2015)
"Leukocytes interact with cancer cells both in the bloodstream and at the site of solid tumors."2.52Leukocytes as carriers for targeted cancer drug delivery. ( King, MR; Mitchell, MJ, 2015)
"Anti-cancer nanomedicines do not require specific target sites on key proteins or genes to kill cancer cells and have radically different mechanisms to interact with the living matter."2.52Anti-cancer cytotoxic effects of multiwalled carbon nanotubes. ( Fanarraga, ML; Fernandez-Luna, JL; Garcia-Hevia, L; Gonzalez, J; Valiente, R; Villegas, JC, 2015)
"Radiofrequency (RF)-assisted cancer therapy is well-known in the medical field as it is non-hazardous and can penetrate tissues, enabling a deeply rooted cancer treatment."2.52Radio frequency responsive nano-biomaterials for cancer therapy. ( Jayakumar, R; Kim, YC; Rejinold, NS, 2015)
" The reactive oxygen species-mediated toxic mechanism of carbon nanotubes has been extensively discussed and strategies, such as surface modification, have been proposed to reduce the toxicity of these materials."2.50Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine. ( Ali, S; Biris, AS; Casciano, D; Karmakar, A; Mahmood, M; Petibone, D; Xu, Y; Zhang, Y, 2014)
"The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality."2.50Nanobiosensors: role in cancer detection and diagnosis. ( Gdowski, A; Mukerjee, A; Ranjan, AP; Vishwanatha, JK, 2014)
"In the search to improve anticancer therapies, several drug carriers, including carbon-based nanomaterials have been studied."2.50Carbon-based drug delivery carriers for cancer therapy. ( Lim, DJ; Lim, K; Oh, L; Park, H; Sim, M, 2014)
" Publishing adverse events associated with novel materials is critically important for alerting people exposed to such materials."2.49Genotoxicity and carcinogenicity risk of carbon nanotubes. ( Toyokuni, S, 2013)
" For providing a guide to develop safe drug carriers, this review discusses the functionalization, toxicity and pharmacokinetics of carbon nanotubes."2.49The toxicity and pharmacokinetics of carbon nanotubes as an effective drug carrier. ( Hu, J; Li, Y; Lin, Y; Luo, E; Shi, P; Song, G, 2013)
"Moreover, the alternative anticancer therapies based on thermal ablation and radiotherapy are discussed."2.48Targeting carbon nanotubes against cancer. ( Ali-Boucetta, H; Bianco, A; Da Ros, T; Fabbro, C; Kostarelos, K; Prato, M, 2012)
"The success of detecting cancer at early stages relies greatly on the sensitivity and specificity of in vivo molecular imaging."2.48Near infrared receptor-targeted nanoprobes for early diagnosis of cancers. ( Cheng, K; Cheng, Z, 2012)
"Different cancer detection techniques like Carbon Nanotubes (CNTs), nanorods and biosensors are available."2.48Application of nanotechnology in cancer: a review. ( Kolhe, S; Parikh, K, 2012)
"Cancer is one of the main causes of death in the world, and according to the WHO it is projected to continue rising."2.47Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. ( De La Peña, H; Pastorin, G; Rajadas, J; Seifalian, A; Tan, A; Yildirimer, L, 2011)
"malignant mesothelioma and lung cancer) is largely unknown."2.46Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. ( Nagai, H; Toyokuni, S, 2010)
" Functionalized SWNTs with significantly reduced toxicity have been employed as carriers to deliver various anticancer drugs, proteins and nucleic acids to the diseased tissues specifically and maximize the bioavailability of the drugs by improving solubility and increasing circulation time."2.46A review on biomedical applications of single-walled carbon nanotubes. ( Chen, B; Liang, F, 2010)
"The application of nanotechnology for cancer therapy has received considerable attention in recent years."2.46Cancer nanotechnology: application of nanotechnology in cancer therapy. ( Acharya, S; Misra, R; Sahoo, SK, 2010)
"A long-standing problem in cancer chemotherapy is the lack of tumor-specific treatments."2.44Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads. ( Ojima, I, 2008)
"The National Cancer Institute has recognized that nanotechnology offers an extraordinary, paradigm-changing opportunity to make significant advances in cancer diagnosis and treatment."2.43Emerging implications of nanotechnology on cancer diagnostics and therapeutics. ( Cance, WG; Cuenca, AG; Delano, M; Grobmyer, SR; Hochwald, SN; Jiang, H, 2006)
"After effective competition between cancer cells and the anchored mannose, a decreased current was obtained as the cell concentration increased."1.91Competitive electrochemical sensing for cancer cell evaluation based on thionine-interlinked signal probes. ( Huang, Q; Li, X; Wang, Z; Xiao, W; Zhang, X; Zhou, L; Zou, X, 2023)
"Conventional cancer therapies are associated with toxicity toward healthy cells, which need to be addressed by novel therapeutic approaches."1.72Potential of novel self-assembled functionalized carbon nanotubes for selective tumor targeting. ( Kumar, N; Kumar, S; R Kannan, B; Sabanis, CD, 2022)
"Since cancer tissues pH is acidic, this shows the suitability of carbon nanotube in drug delivery and DOXORUBICIN release in cancer tissues."1.56pH-sensitive loading/releasing of doxorubicin using single-walled carbon nanotube and multi-walled carbon nanotube: A molecular dynamics study. ( Afrouzi, HH; Hosseini, M; Maleki, R; Piranfar, A; Rostami, S; Toghraie, D, 2020)
"In vitro growth of cancer spheroids (CSs) and the subsequent separation of CSs from a 2D or 3D cell culture system are important for fundamental cancer studies and cancer drug screening."1.56Aqueous Suspensions of Cellulose Oligomer Nanoribbons for Growth and Natural Filtration-Based Separation of Cancer Spheroids. ( Maeda, T; Sawada, T; Serizawa, T; Yamaguchi, S, 2020)
"Cell free diagnosis of cancer is one of the crucial fields in new generation of medical technology."1.51Carbon nanotube based dielectric spectroscopy of tumor secretion; electrochemical lipidomics for cancer diagnosis. ( Abbasvandi, F; Abdolahad, M; Assadi, S; Davari Sh, Z; Gilani, A; Gity, M; Hoseinpour, P; Katebi, P; Khayamian, MA; Moghtaderi, H; Parizi, MS; Saghafi, M; Sanati, H; Tafti, SR; Zandi, A, 2019)
"The heterogeneity and diversity of tumors seriously attenuate the curative outcome of single treatment modes."1.51Mild Hyperthermia-Enhanced Enzyme-Mediated Tumor Cell Chemodynamic Therapy. ( Dai, Z; Liu, X; Liu, Y; Wang, J; Wei, T, 2019)
"In vivo anticancer experiments demonstrated that DOX/MWCNT NCs not only enhanced the suppression of tumor growth but also decreased the side effects of free DOX."1.48Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors. ( Hu, Y; Shi, X; Song, T; Sun, R; Wang, R; Yan, Y; Yin, S, 2018)
"In GQD-BTN-DOX treated cancer cells, the cytotoxicity was strongly dependent from cell uptake which was greater and delayed after treatment with GQD-BTN-DOX system with respect to what observed for cells treated with the same system lacking of the targeting module BTN (GQD-DOX) or with the free drug alone."1.46Graphene quantum dots for cancer targeted drug delivery. ( Branca, C; Di Pietro, A; Galvagno, S; Giofré, SV; Iannazzo, D; Pistone, A; Romeo, R; Salamò, M; Visalli, G, 2017)
"Therefore, in cancer treatment, both SWNT + LV pulse treatment followed by the injection of LIPO-DOX® and SWNT/DOX + LV pulse treatment can increase tumor inhibition and delay tumor growth."1.43Combining the single-walled carbon nanotubes with low voltage electrical stimulation to improve accumulation of nanomedicines in tumor for effective cancer therapy. ( Lee, PC; Peng, CL; Shieh, MJ, 2016)
"In vivo anticancer studies revealed that Pd1 d significantly inhibited tumor growth in a nude mice model."1.43Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression. ( Che, CM; Chow, PK; Chung, CY; Fong, TT; Fung, YM; Lok, CN; Wan, PK, 2016)
"The number of observed cases of thyroid cancer increased substantially among both sexes over the time period in all counties regardless of the number of wells drilled."1.43Shale gas development and cancer incidence in southwest Pennsylvania. ( Finkel, ML, 2016)
"Gemcitabine (GEM) is an anticancer agent widely used in non-small cell lung and pancreatic cancers."1.43In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. ( Atyabi, F; Dinarvand, R; Kazemi, B; Razzazan, A, 2016)
"Silicon carbide was classified into silicon carbide fibers and whiskers."1.43Evaluations of the Carcinogenicity of Carbon Nanotubes, Fluoro-Edinite, and Silicon Carbide by the International Agency for Research on Cancer (IARC). ( Kobayashi, N; Morimoto, Y, 2016)
"The orthotopic liver cancer mice were established as deep-seated tumor model to investigate the anti-tumor effect of mitochondria-targeting TA therapy."1.43Microwave pumped high-efficient thermoacoustic tumor therapy with single wall carbon nanotubes. ( Ding, W; Wen, L; Xing, D; Yang, S, 2016)
"Inhibiting cancer cell migration and infiltration to other tissues makes the difference between life and death."1.42Inhibition of Cancer Cell Migration by Multiwalled Carbon Nanotubes. ( Fanarraga, ML; Fernández-Luna, JL; Flahaut, E; García-Hevia, L; González, J; Rodríguez-Fernández, L; Valiente, R; Villegas, JC, 2015)
"Furthermore, the captured cancer cells on the cytosensor also could be directly visualized by optical microscopy technology."1.42Sensitive detection of tumor cells by a new cytosensor with 3D-MWCNTs array based on vicinal-dithiol-containing proteins (VDPs). ( Chen, S; Hao, C; Huang, C; Jia, N; Miao, C; Wu, B; Wu, H; Xu, Y, 2015)
"By targeting CD44-overexpressing MDR cancer cells, we have developed in a single-step a self-assembled, self-targetable, therapeutic semiconducting single-walled carbon nanotube (sSWCNT) drug delivery system that can deliver chemotherapeutic agents to both drug-sensitive OVCAR8 and resistant OVCAR8/ADR cancer cells."1.40Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance. ( Bhirde, AA; Chen, X; Chikkaveeraiah, BV; Gorbach, AM; Gutkind, JS; Hight Walker, AR; Jin, AJ; Kapoor, A; Leapman, RD; Niu, G; Patel, S; Patel, V; Srivatsan, A; Wang, Z, 2014)
"Malignant cancer is the leading cause of death in man, exceeding cerebrovascular disease and heart disease."1.40Chinese medicine single-walled carbon nanotube targeting compound for antitumor therapy: a feasible way? ( Hu, GJ; Lai, ZF; Li, J; Li, YL; Yan, CY, 2014)
"We found strong cytotoxic effects in cancer cells, accompanied by an immediate and irreversible loss of mitochondrial respiration as well as by a crucial imbalance of the intracellular redox state, resulting in apoptotic cell death."1.40Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene-gold(I) complex. ( Alborzinia, H; Can, S; Cheng, X; Holenya, P; Jünger, A; Ott, I; Rubbiani, R; Wölfl, S, 2014)
"Detection and excision of tumors by a gynecological surgeon improved with SWNT image guidance and led to the identification of submillimeter tumors."1.40Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes. ( Bagley, AF; Belcher, AM; Bhatia, SN; Birrer, MJ; Ghosh, D; Na, YJ, 2014)
"As the majority of side effects of current chemotherapies stems from toxicity due to excessive dosing of anticancer drugs, minimizing the amount of drug while maximizing drug efficacy is essential to increase the life-quality of chemotherapy patients."1.39Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug. ( Choi, J; Choi, WS; Kang, SS; Khang, D; Kim, CJ; Kim, SH; Lee, JK; Lee, S; Lee, YK; Nam, TH; Wang, W, 2013)
"The anti-cancer drug, doxorubicin (DOX), is further loaded on the surface of SWNTs at a very high loading efficiency, 149."1.39Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of Doxorubicin to cancer cells. ( Lu, Q; Meng, L; Niu, L, 2013)
"Through entrapment of various cancer cells on CNT arrays, the deflections of the nanotubes during cell deformation were used to derive the lateral cell shear force using a large deflection mode method."1.39Evaluation of the shear force of single cancer cells by vertically aligned carbon nanotubes suitable for metastasis diagnosis. ( Abdolahad, M; Janmaleki, M; Mohajerzadeh, S; Taghinejad, H; Taghinejad, M, 2013)
"Imaging of cancer cells with SWCNT-PEG-PPa nanoprobe was confirmed using two cancer cell lines via laser scanning confocal microscope tests, and killing of cancer cells with SWCNT-PEG-PPa was demonstrated using cytotoxicity tests."1.39A novel nanoprobe based on single-walled carbon nanotubes/photosensitizer for cancer cell imaging and therapy. ( Ou, Z; Wu, B, 2013)
"The subchronic non-cancer hazard index (HI) of 5 for residents ≤ ½ mile from wells was driven primarily by exposure to trimethylbenzenes, xylenes, and aliphatic hydrocarbons."1.38Human health risk assessment of air emissions from development of unconventional natural gas resources. ( Adgate, JL; McKenzie, LM; Newman, LS; Witter, RZ, 2012)
"Unmodified SWNTs can be taken up into cancer cells due to a higher mitochondrial transmembrane potential in cancerous cells than normal cells."1.38Mitochondria-targeting photoacoustic therapy using single-walled carbon nanotubes. ( Chen, WR; Wu, S; Xing, D; Yuan, Y; Zhou, F, 2012)
"During recent years, cancer cell lines have also been explored as prominent experimental models for evaluating pharmacokinetic parameters, cell viability, cytotoxicity and drug efficacy in tumor cells."1.38Carbon nanotube exploration in cancer cell lines. ( Ghanghoria, R; Jain, NK; Kesharwani, P, 2012)
"110%, in addition to cancer-targeted optical imaging as well as magnetically guided drug delivery."1.38Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery. ( Chen, ML; Chen, XW; He, YJ; Wang, JH, 2012)
" Is it possible to create safe nanomaterials if such a number of complicated factors need to be regulated? We herein try to find answers to this important question."1.37Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. ( Hu, Z; Li, S; Yan, L; Zhao, F; Zhao, Y, 2011)
"Thermotherapy consisting of heating tumors to death appears to be a suitable method to achieve tumor ablation in a noninvasive manner with minimal side effects but developments were hampered because of the lack of specificity of the heating method."1.37Nanoparticles: heating tumors to death? ( Couvreur, P; Tsapis, N; Vauthier, C, 2011)
"Cell viability of murine kidney cancer cells (RENCA) was measured 24 hours following laser treatment with the previously mentioned laser parameters alone or with SWNHs."1.37Single walled carbon nanohorns as photothermal cancer agents. ( Campbell, TA; Do, T; Dorn, HC; Geohegan, DB; Manson, MK; More, KL; Puretzky, AA; Rouleau, CM; Rylander, CG; Rylander, MN; Sarkar, S; Whitney, JR; Young, T; Zhang, J, 2011)
"However, at present, a true anticancer vaccine remains elusive."1.37Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes. ( Iancu, C; Mocan, T, 2011)
"Loading tumors with systematically asministered energy-transducing nanoparticles can circumvent several of the obstacles to achieve tumor hyperthermia."1.37Nanoparticle-mediated hyperthermia in cancer therapy. ( Chatterjee, DK; Diagaradjane, P; Krishnan, S, 2011)
"The approved platinum(II)-based anticancer agents cisplatin, carboplatin and oxaliplatin are widely utilised in the clinic, although with numerous disadvantages."1.36Advances in platinum chemotherapeutics. ( Aldrich-Wright, JR; Garbutcheon-Singh, KB; Grant, MP; Harper, BW; Krause-Heuer, AM; Manohar, M, 2010)
"When ZnPc-SWNHox-BSA was injected into tumors that were subcutaneously transplanted into mice, the tumors almost disappeared upon 670-nm laser irradiation."1.35Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy. ( Ajima, K; Iijima, S; Ito, O; Murakami, T; Sandanayaka, AS; Tsuchida, K; Yudasaka, M; Zhang, M, 2008)
"The death mechanism of cancer cells caused by the photoacoustic explosion of SWNTs is also studied and discussed in detail."1.35Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as "bomb" agents. ( Chang, S; Chen, D; Dai, Y; Ding, Y; Kang, B; Yu, D, 2009)
"Cancer is a leading health hazard, and lung cancer is its most common form."1.35Spongelike structures of hexa-peri-hexabenzocoronene derivatives enhance the sensitivity of chemiresistive carbon nanotubes to nonpolar volatile organic compounds of cancer. ( Feng, X; Haick, H; Müllen, K; Pisula, W; Tisch, U; Zilberman, Y, 2009)
"HeLa and human Panc1 cancer cells were treated with CNTs (24 h, 10 and 20 microg/ml), etoposide (6 h, 75 x 10(-6) M) and their combination."1.35Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug. ( Agarwal, R; Ali, N; Biris, AR; Biris, AS; Dervishi, E; Fejleh, A; Galanzha, EI; Iancu, C; Iancu, DT; Karmakar, A; Li, Z; Mahmood, M; Mocan, L; Mocan, T; Xu, Y; Zharov, VP, 2009)
"To improve drug delivery to cancer cells in the lymph nodes, individualized MNTs were noncovalently functionalized by folic acid (FA)."1.35Magnetic lymphatic targeting drug delivery system using carbon nanotubes. ( Fu, de L; Long, J; Ni, QX; Yang, F, 2008)
"Selective cancer cell destruction can be achieved by functionalization of SWNT with a folate moiety, selective internalization of SWNTs inside cells labeled with folate receptor tumor markers, and NIR-triggered cell death, without harming receptor-free normal cells."1.33Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. ( Dai, H; Kam, NW; O'Connell, M; Wisdom, JA, 2005)
"The shifts observed in the case of cancer patients and neonates are in the direction opposite to the shift measured from the plasma of healthy adults."1.281H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors. ( Eskelinen, S; Hiltunen, Y; Jokisaari, J; Kiviniitty, K; Virtanen, S, 1989)

Research

Studies (334)

TimeframeStudies, this research(%)All Research%
pre-19904 (1.20)18.7374
1990's0 (0.00)18.2507
2000's36 (10.78)29.6817
2010's215 (64.37)24.3611
2020's79 (23.65)2.80

Authors

AuthorsStudies
Abualfaraj, N1
Gurian, PL1
Olson, MS1
Finkel, ML1
McKenzie, LM1
Witter, RZ1
Newman, LS1
Adgate, JL1
Lenis-Rojas, OA1
Cordeiro, S1
Horta-Meireles, M1
Fernández, JAA1
Fernández Vila, S1
Rubiolo, JA1
Cabezas-Sainz, P1
Sanchez, L1
Fernandes, AR1
Royo, B1
Tzouras, NV1
Scattolin, T1
Gobbo, A1
Bhandary, S1
Rizzolio, F1
Cavarzerani, E1
Canzonieri, V1
Van Hecke, K1
Vougioukalakis, GC1
Cazin, CSJ1
Nolan, SP1
Liu, B1
Monro, S1
Jabed, MA1
Cameron, CG1
Colón, KL1
Xu, W3
Kilina, S1
McFarland, SA1
Sun, W2
Holland, JP1
Gut, M1
Klingler, S1
Fay, R1
Guillou, A1
Meier-Menches, SM2
Aikman, B1
Döllerer, D1
Klooster, WT1
Coles, SJ2
Santi, N1
Luk, L1
Casini, A5
Bonsignore, R1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z2
Zhou, L3
Zhao, Y4
Wang, J14
Huang, L2
Hu, K1
Liu, H6
Wang, H5
Guo, Z1
Song, Y3
Huang, H5
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S3
Cheng, T1
Zhou, X3
Wang, B4
Zhang, Q4
Wu, X4
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W7
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X12
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J8
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H3
He, C3
Xiao, Z1
Xu, J4
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L4
Li, X9
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y6
Liu, Z9
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L4
Shao, J2
Sun, M1
Xu, G1
Zhang, X11
Xu, N1
Wang, R5
Liu, S2
He, H1
Dong, X5
Yang, M3
Yang, Q2
Duan, S1
Yu, Y2
Han, J2
Zhang, C7
Chen, L2
Yang, X2
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H10
Yao, L2
Sun, L4
Zhu, Z2
Naren, N1
Zhang, XX3
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH3
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S2
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C2
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Gao, S2
Zhai, X1
Wang, C8
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y13
Hu, Z2
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H4
Zhao, X6
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y11
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L9
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X2
Huang, X2
Xu, H4
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J11
Du, S1
Zhou, H2
Cui, J1
Wu, W1
Liu, Y13
Song, J2
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J2
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A2
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L2
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y4
Zhang, H10
Yu, B3
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J4
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D4
Zheng, S4
Ma, L2
Wang, L8
Hu, T1
Wang, F2
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X2
Dai, T1
Yang, Y6
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y10
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y3
Tang, J4
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z8
Qiu, N1
Yin, J1
Zhang, J9
Guo, W3
Liu, M3
Liu, T2
Chen, D7
Luo, K1
He, Z2
Zheng, G1
Xu, F5
Yin, F1
van Hest, JCM1
Du, L2
Shi, X5
Kang, S1
Duan, W1
Zhang, S5
Feng, J3
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q2
Quan, M1
Dong, J2
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q2
Lyu, HD1
Deng, L2
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C3
Liu, W3
Chen, W1
Yin, Y2
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q3
Xu, Y6
Dong, Q1
Hung, MC1
Ren, N1
Huang, P2
Liao, R1
Chen, X9
Cao, Q1
Yuan, X1
Nie, W1
Yang, J4
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X3
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H2
Cui, Y2
Zhang, L5
Fan, H1
Yu, H2
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C5
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X2
Pang, B1
Liu, Q3
Liu, X7
Huang, Y3
Josephine Fauci, A1
Ma, Y2
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H2
Zheng, W2
Yang, F4
Chua, H1
Wang, K2
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J2
Tian, J1
Zhao, M1
Hu, J4
Yao, C1
Zhang, B4
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W2
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J2
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R2
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C4
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO2
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z2
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y5
Shen, Y2
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z2
Li, Z7
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P2
Mi, K1
Cheng, J1
Gu, C1
Huang, J4
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W3
Ruan, Z1
Li, S3
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z7
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J3
Zhang, M3
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S4
Luo, M1
Wu, J2
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q2
Sherrell, PC1
Chen, J7
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L3
Yuan, Y2
Luo, J2
Ye, S1
Ustriyana, P1
Wei, B2
Raee, E1
Hu, Y3
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S2
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D2
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H2
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D5
Hu, M1
Shen, H1
Yao, M2
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J2
Xiao, W2
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X3
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y2
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P2
Sun, YH1
Zhang, HB1
Bouché, M1
Vincent, B1
Achard, T1
Bellemin-Laponnaz, S1
Sen, S1
Hufnagel, S1
Maier, EY1
Aguilar, I1
Selvakumar, J1
DeVore, JE1
Lynch, VM1
Arumugam, K1
Cui, Z1
Sessler, JL1
Arambula, JF1
Şahin-Bölükbaşı, S1
Cantürk-Kılıçkaya, P1
Kılıçkaya, O1
Karaca, Ö1
Kühn, FE1
Estrada-Ortiz, N1
Guarra, F1
de Graaf, IAM1
Marchetti, L1
de Jager, MH1
Groothuis, GMM1
Gabbiani, C1
Maestro, A1
Martín-Encinas, E1
Alonso, C1
Martinez de Marigorta, E1
Rubiales, G1
Vicario, J1
Palacios, F1
Kankala, S1
Thota, N1
Björkling, F1
Taylor, MK1
Vadde, R1
Balusu, R1
Mora, M1
Gimeno, MC1
Visbal, R1
Groves, LM1
Williams, CF1
Hayes, AJ1
Ward, BD1
Isaacs, MD1
Symonds, NO1
Lloyd, D1
Horton, PN1
Pope, SJA1
Kang, Y1
Kim, J1
Park, J1
Lee, YM1
Saravanakumar, G1
Park, KM1
Choi, W1
Kim, K1
Lee, E1
Kim, C1
Kim, WJ1
Citta, A1
Schuh, E1
Mohr, F1
Folda, A1
Massimino, ML1
Bindoli, A1
Rigobello, MP1
Gandin, V1
Pellei, M1
Marinelli, M1
Marzano, C1
Dolmella, A1
Giorgetti, M1
Santini, C1
Bertrand, B1
Hu, C1
Zhang, R3
Holenya, P1
Can, S1
Rubbiani, R1
Alborzinia, H1
Jünger, A1
Cheng, X1
Ott, I1
Wölfl, S1
Patil, SA2
Patil, R1
Keri, RS1
Budagumpi, S1
Balakrishna, GR1
Tacke, M2
Fung, SK1
Zou, T1
Cao, B1
Chen, T1
To, WP1
Lok, CN2
Che, CM2
Fong, TT1
Chung, CY1
Fung, YM1
Chow, PK1
Wan, PK1
Alves, G1
Morel, L1
El-Ghozzi, M1
Avignant, D1
Legeret, B1
Nauton, L1
Cisnetti, F2
Gautier, A2
Kaps, L1
Biersack, B1
Müller-Bunz, H1
Mahal, K1
Münzner, J1
Mueller, T1
Schobert, R1
Gust, R1
BALLS, M1
Galperin, MY1
Eskelinen, S1
Hiltunen, Y1
Jokisaari, J1
Virtanen, S1
Kiviniitty, K1
Kuriyama, H1
Watanabe, N1
Neda, H1
Yamauchi, N1
Maeda, M1
Niitsu, Y1
Zasypka, AT1
Ali Hazis, NU1
Aneja, N1
Rajabalaya, R1
David, SR1
Sheng, TM1
Kumar, PV1
Yao, S2
Wan, X1
Huang, T3
Sharifianjazi, F1
Jafari Rad, A1
Bakhtiari, A1
Niazvand, F1
Esmaeilkhanian, A1
Bazli, L1
Abniki, M1
Irani, M2
Moghanian, A1
Yadav, A1
Singh, S1
Sohi, H1
Tang, L2
Xiao, Q2
Mei, Y2
He, S1
Laraib, U1
Sargazi, S2
Rahdar, A2
Khatami, M1
Pandey, S1
Dalal, C1
Saini, D1
Garg, AK1
Sonkar, SK1
Ding, Y2
Wang, ZL1
Pan, T1
Du, X1
Zhou, J2
Kalave, S1
Hegde, N1
Juvale, K1
Er, S1
Mobashar, A1
Gelen, SS1
Ebrahimi, N1
Hosseinikhah, SM1
Bilal, M1
Kyzas, GZ1
Han, M1
Zhou, ZH1
Luo, YL1
Chen, YS1
Sabanis, CD1
R Kannan, B1
Kumar, S1
Kumar, N1
Xiao, C1
Lai, C1
Luo, B1
Shen, J2
Al Garalleh, H1
Han, W1
Wei, Z2
Feng, L1
Yadav, DN3
Ali, MS3
Thanekar, AM3
Pogu, SV3
Rengan, AK3
Bagheri, B3
Surwase, SS3
Lee, SS3
Park, H4
Faraji Rad, Z3
Trevaskis, NL3
Kim, YC4
Zou, X1
Huang, Q2
Mal, S1
Duarte E Souza, L1
Allard, C1
David, C1
Blais-Ouellette, S1
Gaboury, L1
Tang, NY1
Martel, R1
Safari, M1
Moghaddam, A1
Salehi Moghaddam, A1
Absalan, M1
Kruppke, B1
Ruckdäschel, H1
Khonakdar, HA1
Hosseini, SM1
Mohammadnejad, J1
Najafi-Taher, R1
Zadeh, ZB1
Tanhaei, M1
Ramakrishna, S1
Aghaei, A1
Shaterian, M1
Danafar, H1
Likozar, B1
Šuligoj, A1
Gyergyek, S1
Yi, W1
Khalid, A1
Arshad, N1
Asghar, MS1
Irshad, MS1
Yi, Y1
Si, J1
Hou, X1
Li, HR1
Naderi, N1
Lalebeigi, F1
Sadat, Z1
Eivazzadeh-Keihan, R1
Maleki, A1
Mahdavi, M1
Wei, M1
Sengupta, J1
Hussain, CM1
Pavelić, K1
Kraljević Pavelić, S1
Bulog, A1
Agaj, A1
Rojnić, B1
Čolić, M1
Trivanović, D1
Samiei, F1
Torshabi, M1
Shirazi, FH1
Azari, MR1
Pourahmad, J1
Gorain, B1
Karmakar, V1
Sarkar, B1
Dwivedi, M1
Leong, JTL1
Toh, JH1
Seah, E1
Ling, KY1
Chen, KY1
Choudhury, H1
Pandey, M1
Bayat, R1
Bekmezci, M1
Akin, M1
Isik, I1
Sen, F1
Ye, Y1
Lei, Y2
Islam, R1
Tan, S1
Tong, R1
Miao, YB1
Cai, L1
Zandi, A3
Gilani, A2
Abbasvandi, F3
Katebi, P1
Tafti, SR1
Assadi, S1
Moghtaderi, H1
Parizi, MS1
Saghafi, M2
Khayamian, MA3
Davari Sh, Z2
Hoseinpour, P1
Gity, M1
Sanati, H1
Abdolahad, M5
Kumar, MS1
Yadav, TT1
Khair, RR1
Peters, GJ1
Yergeri, MC1
Shalileh, S1
Vanaei, S1
Salemizadeh Parizi, M1
Ansaryan, S1
Ebadi, A1
Soltan Khamsi, P1
Cirillo, G1
Peitzsch, C1
Vittorio, O1
Curcio, M1
Farfalla, A1
Voli, F1
Dubrovska, A1
Iemma, F1
Kavallaris, M1
Hampel, S3
Xie, S3
Liu, F1
Tang, C1
Liu, P2
Saiyin, H1
Peng, H2
Maleki, R1
Afrouzi, HH1
Hosseini, M1
Toghraie, D1
Piranfar, A1
Rostami, S1
Zhang, K1
Hujaya, SD1
Järvinen, T1
Li, P2
Kauhanen, T1
Tejesvi, MV1
Kordas, K1
Liimatainen, H1
Hansen, SF1
Lennquist, A1
Mi, Y1
Saghatchi, F1
Mohseni-Dargah, M1
Akbari-Birgani, S1
Saghatchi, S1
Kaboudin, B1
Singh, A2
Hua Hsu, M1
Gupta, N1
Khanra, P1
Kumar, P1
Prakash Verma, V1
Kapoor, M1
Gui, X1
Chen, Y3
Lei, L2
Zhu, F1
Yang, W1
Chu, M1
Yang, N1
Tanner, JA1
Zheng, BJ1
Watt, RM1
He, ML1
Lu, LY1
Jiang, JQ1
Shum, KT1
Lin, YP1
Wong, KL1
Lin, MCM1
Kung, HF1
Sun, H1
Huang, JD1
Marinho, CC1
Nicolato, AJPG1
Reis, VW1
Dos Santos, RC1
Silva, JC1
Faria, HP1
Machado-Coelho, GLL1
Zhang, N2
Sun, B1
Wei, L1
Ball, S1
Dennis, JA1
Bedanie, G1
Nugent, K1
Hayek, AJ1
Scott, V1
Yau, P1
Zolfaghari, K1
Goldwater, M1
Almquist, J1
Arroliga, AC1
Ghamande, S1
Wu, Q1
Ma, W1
Shi, R1
Mao, X1
Sbhatu, DB1
Berhe, GG1
Hndeya, AG1
Abraha, HB1
Abdu, A1
Gebru, HA1
Taye, MG1
Mulugeta, A1
Weldemichael, MY1
Tekle, HT1
Kidanemariam, HG1
Surger, M1
Angelov, A1
Liebl, W1
Hookey, L1
Bertiger, G1
Johnson, KL1
Boules, M1
Ando, M1
Dahdal, DN1
Riedl, JM1
Posch, F1
Prager, G1
Eisterer, W1
Oehler, L1
Sliwa, T1
Wilthoner, K1
Petzer, A1
Pichler, P1
Hubmann, E1
Winder, T1
Burgstaller, S1
Korger, M1
Andel, J1
Greil, R1
Neumann, HJ1
Pecherstorfer, M1
Philipp-Abbrederis, K1
Djanani, A1
Gruenberger, B1
Laengle, F1
Wöll, E1
Gerger, A1
Evans, WE1
Raynor, HA1
Howie, W1
Lipton, RB1
Thomas, GJ1
Wing, RR1
Pavlovic, J1
Farris, SG1
Bond, DS1
Hepprich, M1
Antwi, K1
Waser, B1
Reubi, JC1
Wild, D1
Christ, ER1
Braüner Christensen, J1
Aasbrenn, M1
Sandoval Castillo, L1
Ekmann, A1
Giver Jensen, T1
Pressel, E1
Haxholdt Lunn, T1
Suetta, C1
Palm, H1
Mansour, FA1
Al-Mazrou, A1
Al-Mohanna, F1
Al-Alwan, M1
Ghebeh, H1
Brown-Johnson, C1
Safaeinili, N1
Zionts, D1
Holdsworth, LM1
Shaw, JG1
Asch, SM1
Mahoney, M1
Winget, M1
Luo, Y2
Shan, H1
Gao, X1
Qi, P1
Li, B2
Rong, X1
Shen, B1
Lin, F1
Tang, Z1
Peng, Z3
Jimenez, JL1
Ayer, GB1
Klepov, VV1
Pace, KA1
Zur Loye, HC1
Acquaroni, M1
Svartz, G1
Pérez Coll, C1
Otludil, B1
Ayaz, S1
Hill, A1
Elakkad, A1
Kuban, J1
Sabir, S1
Odisio, B1
Huang, SY1
Mahvash, A1
Miller, E1
Kroll, MH1
Overman, M1
Tam, AL1
Gupta, S1
Sheth, RA1
Deandreis, D1
Guarneri, A1
Ceci, F1
Lillaz, B1
Bartoncini, S1
Oderda, M1
Nicolotti, DG1
Pilati, E1
Passera, R1
Zitella, A1
Bellò, M1
Parise, R1
Carlevato, R1
Ricardi, U1
Gontero, P1
Coyne, GO'1
Zlott, J1
Juwara, L1
Covey, JM1
Beumer, JH1
Cristea, MC1
Newman, EM1
Koehler, S1
Nieva, JJ1
Garcia, AA1
Gandara, DR1
Miller, B1
Khin, S1
Miller, SB1
Steinberg, SM1
Rubinstein, L1
Parchment, RE1
Kinders, RJ1
Piekarz, RL1
Kummar, S1
Chen, AP1
Doroshow, JH1
Gan, L1
Tian, Y1
Shi, B1
Li, G1
Wu, D1
Wen, A1
Koyappayil, A1
Chavan, SG1
Mohammadniaei, M1
Go, A1
Hwang, SY1
Lee, MH1
Kurokawa, Y1
Yamashita, K1
Kawabata, R1
Fujita, J1
Imamura, H1
Takeno, A1
Takahashi, T1
Yamasaki, M1
Eguchi, H1
Doki, Y1
Schulte, T1
Sala, BM1
Nilvebrant, J1
Nygren, PÅ1
Achour, A1
Shernyukov, A1
Agback, T1
Agback, P1
Karami, H1
Shariatifar, N1
Nazmara, S1
Moazzen, M1
Mahmoodi, B1
Mousavi Khaneghah, A1
Sinha, N1
Mukhopadhyay, S1
Sau, M1
Qi, Y1
Wan, M1
Abd El-Aty, AM1
Cao, L1
She, Y1
Shao, Y2
Jin, F1
Wang, S1
Melendez-Araújo, MS1
Lemos, KGE1
Arruda, SLM1
Dutra, ES1
de Carvalho, KMB1
de la Plaza Llamas, R1
Díaz Candelas, DA1
Ramia, JM1
Zhu, S1
Xiang, Z1
Lan, J1
Yu, M1
Sirajudeen, AAO1
Annuar, MSM1
Subramaniam, R1
Somme, F1
Montaz-Rosset, MS1
Averous, G1
Deur, J1
Goichot, B1
Bachellier, P1
Addeo, P1
Imperiale, A1
Song, S2
Mo, L1
Fan, W1
Yan, Y2
Tong, X1
Yan, H3
Chen, HC1
Chen, YF1
Lu, YJ1
Wong, KT1
Chu, CW1
Banijamali, AR1
Carvalho, AE1
Wakefield, JD1
Germano, P1
Barden, TC1
Tobin, JV1
Zimmer, DP1
Masferrer, JL1
Profy, AT1
Currie, MG1
Todd Milne, G1
Yang, H2
Dang, Z1
Zhan, S1
Sun, C2
Hu, G2
Lin, Y4
Karayağiz Muslu, G1
Özdemir, M1
Del Prete, S1
Nocentini, A1
Supuran, CT1
Capasso, C1
Chagas, ATA1
Ludwig, S1
Pimentel, JDSM1
de Abreu, NL1
Nunez-Rodriguez, DL1
Leal, HG1
Kalapothakis, E1
Dodig, D1
Kovačić, S1
Matana Kaštelan, Z1
Žuža, I1
Benić, F1
Slaven, J1
Miletić, D1
Rumboldt, Z1
Fernandez-Botran, R1
Wellmann, IA1
Une, C1
Méndez-Chacón, E1
Hernández de Rodas, E1
Bhandari, B1
Villagrán de Tercero, CI1
Nguyen, HTT1
Romano, F1
Wampfler, R1
Mühlethaler, K1
Tannich, E1
Oberli, A1
Xiang, T1
Dai, L1
Zuo, D1
Sui, Y1
Zheng, H1
Qiu, C1
Jin, H2
Kerwin, J1
Khan, I1
Rajasekhar, B1
Venkateshwaran, U1
Durairaj, N1
Divyapriya, G1
Nambi, IM1
Joseph, A1
Aliste, M1
Garrido, I1
Flores, P1
Hellín, P1
Vela, N1
Navarro, S1
Fenoll, J1
Panigrahi, BK1
Nayak, AK1
Faraji Dizaji, B1
Khoshbakht, S1
Farboudi, A1
Azarbaijan, MH1
Bhatia, R1
Sharma, A1
Narang, RK1
Rawal, RK1
Jing, X1
Meng, L5
Mangla, B1
Javed, S1
Kohli, K1
Ahsan, A1
Ahsan, W1
Aoki, K1
Ogihara, N1
Tanaka, M1
Haniu, H1
Saito, N1
Serizawa, T1
Maeda, T1
Yamaguchi, S1
Sawada, T1
Paliwal, SR1
Kenwat, R1
Maiti, S1
Paliwal, R1
Khan, AA2
Allemailem, KS1
Almatroudi, A2
Almatroodi, SA1
Mahzari, A1
Alsahli, MA2
Rahmani, AH2
Wen, J1
Hevia, LG1
Fanarraga, ML4
Golubewa, L1
Timoshchenko, I1
Romanov, O1
Karpicz, R1
Kulahava, T1
Rutkauskas, D1
Shuba, M2
Dementjev, A1
Svirko, Y1
Kuzhir, P1
Attri, A1
Thakur, D1
Kaur, T1
Sensale, S1
Kumar, D1
Singh, RP2
Vázquez-González, M1
Willner, I1
Biswas, S1
Lan, Q1
Shende, P1
Pathan, N1
Sun, S1
Ming, T1
Xing, Y1
Xiong, Y1
Yan, S1
Cai, X1
Sajjadi, M1
Nasrollahzadeh, M1
Jaleh, B1
Soufi, GJ1
Iravani, S1
Shen, M2
Gaihre, B1
George, MN1
Tilton, M1
Yaszemski, MJ1
Lu, L1
Zare, H1
Ahmadi, S1
Ghasemi, A1
Ghanbari, M1
Rabiee, N1
Bagherzadeh, M1
Karimi, M1
Webster, TJ1
Hamblin, MR1
Mostafavi, E1
Kim, B1
Park, JE1
Im, E1
Cho, Y1
Lee, J1
Lee, HJ1
Sim, DY1
Park, WY1
Shim, BS1
Kim, SH2
S Allemailem, K1
Aljaghwani, A1
M El-Kady, A1
Kapalatiya, H1
Madav, Y1
Tambe, VS1
Wairkar, S1
Yunus, MA1
Ramli, MM1
Osman, NH1
Mohamed, R1
Shojaeian, F1
Mousavi-Kiasary, SMS1
Saghafi, Z1
Kordehlachin, Y1
Mamdouh, A1
Miraghaie, SH1
Hoseinyazdi, M1
Anbiaee, R1
Faranoush, M1
Costa, C1
Miozzi, E1
Teodoro, M1
Briguglio, G1
Rapisarda, V1
Fenga, C1
Xie, J1
Zhou, M1
Lu, H1
Chai, Z1
Augustine, S1
Singh, J1
Srivastava, M1
Sharma, M1
Das, A1
Malhotra, BD1
Khosravi, F1
Loeian, SM1
Panchapakesan, B1
Sheikhpour, M1
Golbabaie, A1
Kasaeian, A1
Ding, X1
Su, Y2
Zhang, F2
Chen, K1
Li, M2
Leng, X1
Charbgoo, F1
Nikkhah, M1
Behmanesh, M1
Voronkova, MA1
Luanpitpong, S1
Rojanasakul, LW1
Castranova, V2
Dinu, CZ1
Riedel, H1
Rojanasakul, Y1
Sui, J1
Liu, G1
Yu, W1
Ren, Y1
Yu, D2
Jurj, A1
Braicu, C2
Pop, LA1
Tomuleasa, C1
Gherman, CD1
Berindan-Neagoe, I1
Din, FU1
Aman, W1
Ullah, I1
Qureshi, OS1
Mustapha, O1
Shafique, S1
Zeb, A1
Shen, XT1
Li, YY1
Xu, SQ1
Comparetti, EJ1
Pedrosa, VA1
Kaneno, R1
Chen, B2
Sheikholeslam, M1
Wheeler, SD1
Duke, KG1
Marsden, M1
Pritzker, M1
Chen, P2
Pardo, J1
Leblanc, RM1
Tian, K1
Zhou, T1
Jia, X1
Huang, HY1
Chen, LQ1
Cui, JH1
Lee, BJ1
Cao, QR1
Assali, M1
Zaid, AN1
Kittana, N1
Hamad, D1
Amer, J1
Mahajan, S1
Patharkar, A1
Kuche, K1
Maheshwari, R1
Deb, PK1
Kalia, K1
Tekade, RK1
Saha, LC1
Nag, OK1
Doughty, A1
Chen, WR3
Ning, J1
Liu, L2
Wang, M1
Liu, D1
Hou, R1
Sun, R1
Song, T1
Yin, S1
Zhu, C1
Du, D1
Shan, Y1
Cong, H1
Wen, Y1
Xu, M1
Sang, H1
Grushevskaya, HV1
Krylova, NG1
Hassan, HAFM1
Diebold, SS1
Smyth, LA1
Walters, AA1
Lombardi, G1
Al-Jamal, KT2
Ghoreishi, R1
Kia, M1
Gargiulo, S1
Albanese, S1
Mancini, M1
Wei, T1
Dai, Z1
Iannazzo, D2
Piperno, A1
Pistone, A2
Grassi, G1
Galvagno, S2
Adeli, M1
Soleyman, R1
Beiranvand, Z1
Madani, F1
Janmaleki, M2
Taghinejad, M2
Taghnejad, H1
Salehi, F1
Mohajerzadeh, S2
Singh, R2
Mehra, NK3
Jain, V1
Jain, NK5
Lamanna, G1
Garofalo, A1
Popa, G1
Wilhelm, C1
Bégin-Colin, S1
Felder-Flesch, D1
Bianco, A5
Gazeau, F1
Ménard-Moyon, C2
Niu, L2
Lu, Q3
Huang, R1
Gao, Q1
Ou, Z1
Wu, B3
Ding, W2
Gou, Y1
Xu, K1
Xia, G1
Ding, Q1
Chen, C2
Hou, L1
Toyokuni, S2
Kashanian, S1
Khodaei, MM1
Roshanfekr, H1
Peyman, H1
Cui, L1
Ke, G1
Guan, Z1
Yang, CJ1
Scheinberg, DA3
McDevitt, MR3
Dao, T1
Mulvey, JJ2
Feinberg, E1
Alidori, S1
Torti, SV2
Wong, BS1
Yoong, SL1
Jagusiak, A1
Panczyk, T1
Ho, HK1
Ang, WH2
Pastorin, G2
Luo, E1
Song, G1
Shi, P1
Gottardi, R1
Douradinha, B1
Lee, YK1
Lee, S1
Nam, TH1
Choi, WS1
Kim, CJ1
Lee, JK1
Kang, SS1
Khang, D1
Villa, CH2
Escorcia, FE2
Casey, E1
Hashida, Y1
Tanaka, H1
Zhou, S1
Kawakami, S1
Yamashita, F1
Murakami, T3
Umeyama, T1
Imahori, H1
Hashida, M1
Lim, DJ1
Sim, M1
Oh, L1
Lim, K1
Heseltine, P1
Das, M3
Petibone, D1
Mahmood, M2
Karmakar, A2
Casciano, D1
Ali, S1
Biris, AS4
Chai, Y1
Cao, Y1
Bai, L1
Asav, E1
Sezgintürk, MK1
Xia, W1
Verma, AK1
Mishra, PR1
Gdowski, A1
Ranjan, AP1
Mukerjee, A1
Vishwanatha, JK1
Bhirde, AA1
Chikkaveeraiah, BV1
Srivatsan, A1
Niu, G1
Jin, AJ1
Kapoor, A1
Patel, S1
Patel, V1
Gorbach, AM1
Leapman, RD1
Gutkind, JS1
Hight Walker, AR1
Bhatnagar, I1
Venkatesan, J1
Kiml, SK1
Kit, OI1
Zlatnik, EY1
Peredreyeva, LV1
Chervonobrodov, SP1
Bajaj, P1
Mikoryak, C1
Bushdiecker, DK1
Memon, P1
Draper, RK1
Dieckmann, GR1
Pantano, P1
Musselman, IH1
Gong, F1
Hongyan, Z1
Papavassiliou, DV1
Bui, K1
Lim, C1
Duong, HM1
Mundra, RV1
Sauer, J1
Dordick, JS1
Kane, RS1
Fayazfar, H1
Afshar, A1
Dolati, M1
Dolati, A1
Ding, J1
Wei, K1
Weng, J1
Matsumura, S1
Yuge, R1
Sato, S1
Tomida, A1
Ichihashi, T1
Irie, H1
Iijima, S3
Shiba, K1
Yudasaka, M3
de Faria, PC1
dos Santos, LI1
Coelho, JP1
Ribeiro, HB1
Pimenta, MA1
Ladeira, LO1
Gomes, DA1
Furtado, CA1
Gazzinelli, RT1
Yan, L2
Shi, H1
He, X1
Chen, M2
Ye, X1
Ghosh, M1
Brahmachari, S1
Das, PK1
Herreros, E1
Morales, S1
Cortés, C1
Cabaña, M1
Peñaloza, JP1
Jara, L1
Geraldo, D1
Otero, C1
Fernández-Ramires, R1
Ghosh, D1
Bagley, AF1
Na, YJ1
Birrer, MJ1
Bhatia, SN1
Belcher, AM1
García-Hevia, L3
Fernández, F1
Grávalos, C1
García, A1
Villegas, JC3
Mitchell, MJ1
King, MR1
Wu, H1
Huang, C1
Hao, C1
Miao, C1
Jia, N1
Grosse, Y1
Loomis, D1
Guyton, KZ1
Lauby-Secretan, B1
El Ghissassi, F1
Bouvard, V1
Benbrahim-Tallaa, L1
Guha, N1
Scoccianti, C1
Mattock, H1
Straif, K1
Zakaria, AB1
Picaud, F1
Rattier, T1
Pudlo, M1
Dufour, F1
Saviot, L1
Chassagnon, R1
Lherminier, J1
Gharbi, T1
Micheau, O1
Herlem, G1
Valiente, R2
Gonzalez, J2
Fernandez-Luna, JL2
Rejinold, NS1
Jayakumar, R1
Smith, BE1
Roder, PB1
Pauzauskie, PJ1
Al Faraj, A2
Shaik, AS1
Al Sayed, B1
Kesharwani, P2
Mishra, V1
Flahaut, E1
Rodríguez-Fernández, L1
Jiang, Y1
Han, E1
Meliţă, ED1
Purcel, G1
Grumezescu, AM1
Rong, P1
Zong, S1
Zhu, D1
Chen, H2
Wu, L1
Chakrabarti, M1
Kiseleva, R1
Vertegel, A1
Ray, SK1
Anbarasan, B1
Babu, SV1
Elango, K1
Shriya, B1
Ramaprabhu, S1
Chen, A1
Xia, M1
Meng, G1
Kang, B2
Wei, J1
Wen, L1
Xing, D3
Jang, H1
Braatz, RD1
Spinato, C1
Perez Ruiz de Garibay, A1
Kierkowicz, M1
Pach, E1
Martincic, M1
Klippstein, R1
Bourgognon, M1
Wang, JT1
Ballesteros, B1
Tobias, G1
Kaur, P1
Aliru, ML1
Chadha, AS1
Asea, A1
Krishnan, S2
Lee, PC1
Peng, CL1
Shieh, MJ1
Fan, X1
Wang, G1
Tian, R1
Fu, G1
Yang, L1
Alizadeh-Ghodsi, M1
Zavari-Nematabad, A1
Hamishehkar, H1
Akbarzadeh, A1
Mahmoudi-Badiki, T1
Zarghami, F1
Pourhassan Moghaddam, M1
Alipour, E1
Zarghami, N1
Razzazan, A1
Atyabi, F1
Kazemi, B1
Dinarvand, R1
Ning, B1
Harp, MG1
Culp, SH1
Hu, S1
Nie, L1
Zhao, H1
Chao, Y1
Pan, J1
Sheng, M1
Yang, K2
Madhurantakam, S1
Jayanth Babu, K1
Balaguru Rayappan, JB1
Krishnan, UM1
Morimoto, Y1
Kobayashi, N1
Guillaume, YC2
Lethier, L1
André, C2
Karami, P1
Majidi, MR1
Johari-Ahar, M1
Barar, J1
Omidi, Y1
Hunter, P1
Ding, C1
Tong, L1
Fu, J1
Salamò, M1
Romeo, R1
Giofré, SV1
Branca, C1
Visalli, G1
Di Pietro, A1
Sanginario, A1
Miccoli, B1
Demarchi, D1
Darrigues, E2
Nima, ZA2
Majeed, W1
Vang-Dings, KB2
Dantuluri, V2
Biris, AR3
Zharov, VP2
Griffin, RJ2
Ghosh, A1
de Barros, ALB1
Soares, DCF1
Moss, SN1
Alisaraie, L1
Sawada, H1
Tamura, G1
Tsuchida, K2
Meng, J3
Kong, H2
Gu, N1
Yang, XD1
Ajima, K1
Sandanayaka, AS1
Ito, O1
Klingeler, R2
Büchner, B2
Carter, A1
Bordelon, DE1
Graboski, S1
Cox, A1
Schreiber, E1
Zhou, OZ1
Chang, S2
Zeineldin, R1
Al-Haik, M1
Hudson, LG1
Schreiber, EC2
Chang, SX2
Dai, Y1
Zilberman, Y2
Tisch, U2
Pisula, W2
Feng, X2
Müllen, K2
Haick, H2
Rey, DA1
Bergkvist, M1
Batt, CA1
Pan, B1
Cui, D1
Xu, P1
Ozkan, C1
Feng, G1
Ozkan, M1
Chu, B1
Li, Q1
He, R1
Wang, SH1
Antwerp, ME1
Petersen, EJ1
Weber, WJ1
Baker, JR1
Kuznetsova, LV1
Wong, SS1
Ojima, I2
Bellucci, S1
Chiaretti, M1
Cucina, A1
Carru, GA1
Chiaretti, AI1
Fei, Z1
Dyson, PJ1
Ghosh, S1
Dutta, S1
Gomes, E1
Carroll, D1
D'Agostino, R1
Olson, J1
Guthold, M1
Gmeiner, WH1
Fan, AC1
Rakhra, K1
Sherlock, S1
Goodwin, A1
Felsher, DW1
Mohammed, OF1
Samartzis, PC1
Zewail, AH1
Moon, HK1
Lee, SH1
Choi, HC1
Liang, F1
Fejleh, A1
Mocan, T2
Iancu, C3
Mocan, L2
Iancu, DT1
Dervishi, E1
Agarwal, R1
Ali, N1
Galanzha, EI1
Lay, CL1
Liu, HQ1
Tan, HR1
Ji, SR1
Long, J2
Jin, C1
Fu, DL1
Ni, QX2
Yu, XJ1
Jia, F1
Xing, J1
Burlaka, A1
Lukin, S1
Prylutska, S1
Remeniak, O1
Prylutskyy, Y1
Maksimenko, S1
Ritter, U1
Scharff, P1
Bai, Y1
Yan, B2
Shuster, G1
Harper, BW1
Krause-Heuer, AM1
Grant, MP1
Manohar, M1
Garbutcheon-Singh, KB1
Aldrich-Wright, JR1
Nagai, H1
Arlt, M1
Haase, D1
Oswald, S1
Bachmatiuk, A1
Schulze, R1
Ritschel, M1
Leonhardt, A1
Fuessel, S1
Kraemer, K1
Wirth, MP1
Misra, R1
Acharya, S1
Sahoo, SK1
Tang, MF1
Guo, SR1
Huang, WL1
Zhao, J1
Jin, J1
Wu, C1
Zuo, J1
Tao, H1
Lee, ST2
Teng, Y1
Fu, Y1
He, B1
Thakare, VS1
Jain, AK1
Patil, S1
Jain, S2
Zhao, F1
Vauthier, C1
Tsapis, N1
Couvreur, P1
Whitney, JR1
Sarkar, S1
Do, T1
Young, T1
Manson, MK1
Campbell, TA1
Puretzky, AA1
Rouleau, CM1
More, KL1
Geohegan, DB1
Rylander, CG1
Dorn, HC1
Rylander, MN1
Stacey, M1
Osgood, C1
Kalluri, BS1
Cao, W1
Elsayed-Ali, H1
Abdel-Fattah, T1
Demming, A1
Prakash, S1
Malhotra, M1
Shao, W1
Tomaro-Duchesneau, C1
Abbasi, S1
Zhou, F2
Fujigaya, T1
Yamamoto, Y1
Kano, A1
Maruyama, A1
Nakashima, N1
Wan, Y1
Deng, W1
Peng, C1
Fan, C1
Tan, A1
Yildirimer, L1
Rajadas, J1
De La Peña, H1
Seifalian, A1
Prickett, WM1
Van Rite, BD1
Resasco, DE1
Harrison, RG1
Tu, Q1
Chang, C1
Chin, CF1
Wong, DY1
Jothibasu, R1
Bonner, JC1
Zheng, TT1
Zou, L1
Zhu, JJ1
Liao, X1
Ge, L1
Yan, M1
Song, X1
Ge, S1
Zealley, B1
de Grey, AD1
Gulati, N1
Gupta, H1
Li, YL1
Yan, CY1
Lai, ZF1
Hu, GJ1
Schulte, PA1
Kuempel, ED1
Zumwalde, RD1
Geraci, CL1
Schubauer-Berigan, MK1
Hodson, L1
Murashov, V1
Dahm, MM1
Ellenbecker, M1
Rahman, M1
Ahmad, MZ1
Kazmi, I1
Akhter, S1
Afzal, M1
Gupta, G1
Jalees Ahmed, F1
Anwar, F1
Fabbro, C1
Ali-Boucetta, H1
Da Ros, T1
Kostarelos, K2
Prato, M2
Kolhe, S1
Parikh, K1
Cheng, L1
Zhuang, J1
Miró, M1
Gao, Z1
Chen, G1
Tang, D1
Chatterjee, DK1
Diagaradjane, P1
Yang, KS1
Yun, JS1
Kim, JC1
Min, J1
Park, TJ1
Ahn, JK1
Kim, DH1
Ghanghoria, R1
Glazer, ES1
Curley, SA1
Neagoe, IB1
Matea, C1
Bele, C1
Florin, G1
Gabriel, K1
Veronica, C1
Irimie, A1
Cheng, K1
Cheng, Z1
Lin, J1
Shao, M1
Prabhu, P1
Patravale, V1
Diao, S1
Hong, G1
Robinson, JT1
Jiao, L1
Antaris, AL1
Wu, JZ1
Choi, CL1
Datir, SR1
Chen, ML1
He, YJ1
Chen, XW1
Wang, JH1
Reichardt, NC1
Martín-Lomas, M1
Penadés, S1
Taghinejad, H1
Kam, NW1
O'Connell, M1
Wisdom, JA1
Sansom, C1
Cuenca, AG1
Hochwald, SN1
Delano, M1
Cance, WG1
Grobmyer, SR1
Gallego, O1
Puntes, V1
Park, DW1
Kim, YH1
Kim, BS1
So, HM1
Won, K1
Kong, KJ1
Chang, H1
Reilly, RM1
Fu, de L1
Byrne, F1
Whelan, O1
Levi, N1
Ucer, B1
Schmid, M1
Torti, FM1
Akman, S1
Ajayan, PM1
Nalamasu, O1
Carroll, DL1
Hartman, KB1
Wilson, LJ1
Schwendner, M1
Ille, S1
Kirschke, JS1
Bernhardt, D1
Combs, SE1
Meyer, B1
Krieg, SM1
Khan, HA1
Ber, R1
Neifert, SN1
Kurland, DB1
Laufer, I1
Kondziolka, D1
Chhabra, A1
Frempong-Boadu, AK1
Lau, D1
Mastella, E1
Molinelli, S1
Magro, G1
Mirandola, A1
Russo, S1
Vai, A1
Mairani, A1
Choi, K1
Fiore, MR1
Fossati, P1
Cuzzocrea, F1
Benazzo, F1
Boriani, S1
Valvo, F1
Orecchia, R1
Ciocca, M1
Savini, A1
Bartolucci, F1
Fidanza, C1
Rosica, F1
Orlandi, G1
Court, L1
Urribarri, J1
Makrigiorgos, M1
Njeh, CF1
Parker, J1
Spurgin, J1
Rhoe, E1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Nanotechnologies Applied to General Surgery and Emergency Surgery: The Buckypaper as a New Fixing Method for Prosthetic Materials in the Treatment of Abdominal Wall Hernias, Diaphragmatic Hernias, Diaphragmatic Rupture, Incisional Hernia and Abdominal Wa[NCT02137018]Phase 1/Phase 230 participants (Actual)Interventional2013-03-31Active, not recruiting
"BP as a Super-light Mesh and as a New Fixing Device for General, Emergency and Prosthetic Surgery. The BP Implantation Effects on Immunity System, on the Metabolism and on Sealing. Preliminary Experimentation of Small Feasibility Study"[NCT02341222]Early Phase 130 participants (Actual)Interventional2008-01-31Active, not recruiting
The Buckypaper as a New Device in the Treatment of Some Solid Cancer and Hematopoietic System Tumors and as a New Fixing Device for Prosthetic Surgery. In Vivo Study on Effects of BP Implantation, Preliminary to Human Surgical Applications[NCT02328352]Phase 1/Phase 230 participants (Anticipated)Interventional2010-10-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

128 reviews available for methane and Neoplasms

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Silver(I)-N-heterocyclic carbene complexes challenge cancer; evaluation of their anticancer properties and in silico studies.
    Drug development research, 2021, Volume: 82, Issue:7

    Topics: Heterocyclic Compounds; Methane; Neoplasms; Silver; Structure-Activity Relationship

2021
On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.
    Chemical communications (Cambridge, England), 2017, Jul-20, Volume: 53, Issue:59

    Topics: Animals; Antineoplastic Agents; Binding Sites; DNA, Neoplasm; Heterocyclic Compounds; Humans; Metals

2017
Silver carbene complexes: An emerging class of anticancer agents.
    Drug development research, 2019, Volume: 80, Issue:2

    Topics: Animals; Antineoplastic Agents; Coordination Complexes; Humans; Methane; Neoplasms; Silver

2019
Recent advances in gold-NHC complexes with biological properties.
    Chemical Society reviews, 2019, Jan-21, Volume: 48, Issue:2

    Topics: Antioxidants; Apoptosis; Coordination Complexes; Gold; Gram-Negative Bacteria; Gram-Positive Bacteri

2019
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
    Dalton transactions (Cambridge, England : 2003), 2014, Mar-21, Volume: 43, Issue:11

    Topics: Alkynes; Animals; Antineoplastic Agents; Humans; Methane; Neoplasms; Organogold Compounds

2014
Metal-N-heterocyclic carbene complexes as anti-tumor agents.
    Current medicinal chemistry, 2014, Volume: 21, Issue:10

    Topics: Antineoplastic Agents; Auranofin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Copper; Gold;

2014
N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Future medicinal chemistry, 2015, Volume: 7, Issue:10

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Coordination

2015
Advances in metal-carbene complexes as potent anti-cancer agents.
    Metallomics : integrated biometal science, 2012, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Cell Line; Coordination Complexes; Heterocyclic Compounds; Humans; Metals; Me

2012
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Chemical Society reviews, 2013, Jan-21, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Coordination Complexes; Humans; Methane; Models, Molecular; Neoplasm

2013
Using archaeal genomics to fight global warming and clostridia to fight cancer.
    Environmental microbiology, 2007, Volume: 9, Issue:2

    Topics: Bacteria; Clostridium; Genome, Archaeal; Genome, Bacterial; Genomics; Greenhouse Effect; Humans; Met

2007
Nitromethane.
    IARC monographs on the evaluation of carcinogenic risks to humans, 2000, Volume: 77

    Topics: Animals; Carcinogenicity Tests; Carcinogens; Disease Models, Animal; Environmental Exposure; Female;

2000
[Carcinogenic metabolites of tryptophan].
    Voprosy onkologii, 1969, Volume: 15, Issue:7

    Topics: Animals; Carcinogens; Cattle; Dogs; Female; Humans; Indican; Indoleacetic Acids; Indoles; Methane; M

1969
A New Approach for β-cyclodextrin Conjugated Drug Delivery System in Cancer Therapy.
    Current drug delivery, 2022, Volume: 19, Issue:3

    Topics: beta-Cyclodextrins; Cyclodextrins; Drug Delivery Systems; Nanotubes, Carbon; Neoplasms; Pharmaceutic

2022
Biosensors and nanotechnology for cancer diagnosis (lung and bronchus, breast, prostate, and colon): a systematic review.
    Biomedical materials (Bristol, England), 2021, 12-24, Volume: 17, Issue:1

    Topics: Biosensing Techniques; Bronchi; Colon; Humans; Lung; Male; Nanotechnology; Nanotubes, Carbon; Neopla

2021
Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    AAPS PharmSciTech, 2021, Dec-14, Volume: 23, Issue:1

    Topics: Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Nano

2021
Insights on functionalized carbon nanotubes for cancer theranostics.
    Journal of nanobiotechnology, 2021, Dec-16, Volume: 19, Issue:1

    Topics: Antineoplastic Agents; Drug Carriers; Humans; Mitochondria; Nanotubes, Carbon; Neoplasms; Photosensi

2021
Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
    International journal of biological macromolecules, 2022, Jan-15, Volume: 195

    Topics: alpha-Fetoproteins; Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; CA-19-9 Antigen; Carci

2022
Fluorescent Carbon Nano-onion as Bioimaging Probe.
    ACS applied bio materials, 2021, 01-18, Volume: 4, Issue:1

    Topics: Animals; Biocompatible Materials; Carbon; Fluorescent Dyes; Humans; Nanostructures; Nanotubes, Carbo

2021
Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Theranostics, 2022, Volume: 12, Issue:5

    Topics: Drug Carriers; Drug Delivery Systems; Humans; Nanomedicine; Nanostructures; Nanotubes, Carbon; Neopl

2022
Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer.
    Current pharmaceutical design, 2022, Volume: 28, Issue:38

    Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance

2022
Aptamer-conjugated carbon-based nanomaterials for cancer and bacteria theranostics: A review.
    Chemico-biological interactions, 2022, Jul-01, Volume: 361

    Topics: Bacteria; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms; Oligonucleotides; Precision Medicine

2022
The Application of Carbon Nanomaterials in Sensing, Imaging, Drug Delivery and Therapy for Gynecologic Cancers: An Overview.
    Molecules (Basel, Switzerland), 2022, Jul-13, Volume: 27, Issue:14

    Topics: Drug Delivery Systems; Female; Graphite; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms

2022
Current Advances and Prospects in Carbon Nanomaterials-based Drug Deliver Systems for Cancer Therapy.
    Current medicinal chemistry, 2023, Volume: 30, Issue:24

    Topics: Drug Delivery Systems; Fullerenes; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms; Pharmaceuti

2023
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy.
    Molecular pharmaceutics, 2022, 12-05, Volume: 19, Issue:12

    Topics: Drug Delivery Systems; Nanoparticle Drug Delivery System; Nanotubes, Carbon; Neoplasms; RNA Interfer

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based nanostructures for cancer therapy and drug delivery applications.
    Journal of materials chemistry. B, 2022, 12-14, Volume: 10, Issue:48

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms;

2022
Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection.
    Talanta, 2023, Jun-01, Volume: 258

    Topics: Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Graphite; Nanostructures; Nano

2023
Multifunctional Carbon-Based Nanoparticles: Theranostic Applications in Cancer Therapy and Diagnosis.
    ACS applied bio materials, 2023, 04-17, Volume: 6, Issue:4

    Topics: Nanoparticles; Nanotechnology; Nanotubes, Carbon; Neoplasms; Precision Medicine; Quantum Dots

2023
Recent Progress and Perspective of an Evolving Carbon Family From 0D to 3D: Synthesis, Biomedical Applications, and Potential Challenges.
    ACS applied bio materials, 2023, 06-19, Volume: 6, Issue:6

    Topics: Humans; Nanostructures; Nanotubes, Carbon; Neoplasms; Optical Imaging; Quantum Dots

2023
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
Recent advances on hyperthermia therapy applications of carbon-based nanocomposites.
    Colloids and surfaces. B, Biointerfaces, 2023, Volume: 228

    Topics: Hot Temperature; Humans; Hyperthermia, Induced; Nanocomposites; Nanotubes, Carbon; Neoplasms

2023
CNT and Graphene-Based Transistor Biosensors for Cancer Detection: A Review.
    Biomolecules, 2023, 06-22, Volume: 13, Issue:7

    Topics: Biomarkers, Tumor; Biosensing Techniques; Graphite; Humans; Nanotubes, Carbon; Neoplasms

2023
Nanoparticles in Medicine: Current Status in Cancer Treatment.
    International journal of molecular sciences, 2023, Aug-15, Volume: 24, Issue:16

    Topics: Gold; Medicine; Metal Nanoparticles; Nanotubes, Carbon; Neoplasms; Silver

2023
Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review.
    International journal of biological macromolecules, 2023, Dec-31, Volume: 253, Issue:Pt 1

    Topics: Drug Delivery Systems; Humans; Liposomes; Nanoparticles; Nanotubes, Carbon; Neoplasms; Plant Extract

2023
Smart nanoparticles for cancer therapy.
    Signal transduction and targeted therapy, 2023, Nov-03, Volume: 8, Issue:1

    Topics: Artificial Intelligence; Gold; Humans; Metal Nanoparticles; Nanotubes, Carbon; Neoplasms; Peptides

2023
Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.
    Current pharmaceutical design, 2019, Volume: 25, Issue:31

    Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Delivery Systems; Drug Re

2019
Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes.
    Nanotoxicology, 2019, Volume: 13, Issue:9

    Topics: Animals; Humans; Inflammation; Nanotubes, Carbon; Neoplasms; Pulmonary Fibrosis

2019
When polymers meet carbon nanostructures: expanding horizons in cancer therapy.
    Future medicinal chemistry, 2019, Volume: 11, Issue:16

    Topics: Animals; Carbon; Humans; Nanomedicine; Nanostructures; Nanotechnology; Nanotubes, Carbon; Neoplasms;

2019
Derivatized Carbon Nanotubes for Gene Therapy in Mammalian and Plant Cells.
    ChemPlusChem, 2020, Volume: 85, Issue:3

    Topics: Animals; Cell Line; Cell Membrane Permeability; Cell Survival; Gene Transfer Techniques; Genetic The

2020
Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics.
    Current drug delivery, 2020, Volume: 17, Issue:7

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Carriers; Drug Compounding; Environmental Poll

2020
Far-reaching advances in the role of carbon nanotubes in cancer therapy.
    Life sciences, 2020, Sep-15, Volume: 257

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Nanotechnology; Nanotubes, Carbon; Ne

2020
Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Current molecular pharmacology, 2021, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Nano

2021
Reassessment of Therapeutic Applications of Carbon Nanotubes: A Majestic and Futuristic Drug Carrier.
    Critical reviews in therapeutic drug carrier systems, 2020, Volume: 37, Issue:4

    Topics: Animals; Biosensing Techniques; Drug Carriers; Drug Delivery Systems; Humans; Mice; Nanotechnology;

2020
Carbon nanotube-based biomaterials for orthopaedic applications.
    Journal of materials chemistry. B, 2020, 10-21, Volume: 8, Issue:40

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Bone and Bones; Bone Regeneration; Cell Lin

2020
Nanotheranostics for Cancer Therapy and Detection: State of the Art.
    Current pharmaceutical design, 2020, Volume: 26, Issue:42

    Topics: Gold; Humans; Metal Nanoparticles; Nanoparticles; Nanotubes, Carbon; Neoplasms; Theranostic Nanomedi

2020
Endoplasmic Reticulum Stress Provocation by Different Nanoparticles: An Innovative Approach to Manage the Cancer and Other Common Diseases.
    Molecules (Basel, Switzerland), 2020, Nov-16, Volume: 25, Issue:22

    Topics: Animals; Disease; Endoplasmic Reticulum Stress; Humans; Nanoparticles; Nanotubes, Carbon; Neoplasms

2020
Recent Applications of Carbon Nanomaterials for microRNA Electrochemical Sensing.
    Chemistry, an Asian journal, 2021, Jan-18, Volume: 16, Issue:2

    Topics: Biomarkers, Tumor; Biosensing Techniques; DNA Probes; Electrochemical Techniques; Graphite; Humans;

2021
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment.
    Journal of nanobiotechnology, 2020, Dec-14, Volume: 18, Issue:1

    Topics: Apoptosis; Cell Cycle; Centrosome; Cytoskeleton; Humans; Microtubules; Nanotubes, Carbon; Neoplasms;

2020
Aptamer-Functionalized Micro- and Nanocarriers for Controlled Release.
    ACS applied materials & interfaces, 2021, Mar-03, Volume: 13, Issue:8

    Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Delayed-Action Preparations;

2021
Graphene nanoribbons: A state-of-the-art in health care.
    International journal of pharmaceutics, 2021, Feb-15, Volume: 595

    Topics: Animals; Biosensing Techniques; Drug Delivery Systems; Genetic Therapy; Graphite; Humans; Molecular

2021
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects.
    Journal of drug targeting, 2021, Volume: 29, Issue:7

    Topics: Animals; Antineoplastic Agents; Carbon; Drug Delivery Systems; Gene Transfer Techniques; Genetic The

2021
Construction of Poly(amidoamine) Dendrimer/Carbon Dot Nanohybrids for Biomedical Applications.
    Macromolecular bioscience, 2021, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Carbon; Dendrimers; Drug Delivery Systems; Fluorescence; Gene Transf

2021
2D phosphorene nanosheets, quantum dots, nanoribbons: synthesis and biomedical applications.
    Biomaterials science, 2021, Apr-21, Volume: 9, Issue:8

    Topics: Bone and Bones; Humans; Nanotubes, Carbon; Neoplasms; Phosphorus; Quantum Dots

2021
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Drug Carriers; Drug Delivery Systems; Endocytosis; Gene Transfer Techniques; Humans; Nanotubes, Carb

2021
Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.
    International journal of molecular sciences, 2021, Mar-30, Volume: 22, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Humans; Mononuclear Phagocyte Sys

2021
Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Liposomes; Mitochondria; Nanoparticle

2021
Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Drug delivery and translational research, 2022, Volume: 12, Issue:6

    Topics: Drug Carriers; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Nanoparticles; Nanotubes, C

2022
Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression.
    Archivum immunologiae et therapiae experimentalis, 2021, Jul-29, Volume: 69, Issue:1

    Topics: Graphite; Humans; Nanotubes, Carbon; Neoplasms; Oxides

2021
New insights on 'old' toxicants in occupational toxicology (Review).
    Molecular medicine reports, 2017, Volume: 15, Issue:5

    Topics: Asbestos; Benzene; Environmental Pollutants; Humans; Nanotubes, Carbon; Neoplasms; Occupational Dise

2017
Recent advances in carbon based nanosystems for cancer theranostics.
    Biomaterials science, 2017, May-02, Volume: 5, Issue:5

    Topics: Animals; Carbon; Drug Delivery Systems; Fullerenes; Graphite; Humans; Models, Molecular; Nanostructu

2017
Carbon nanotubes: A review of novel strategies for cancer diagnosis and treatment.
    Materials science & engineering. C, Materials for biological applications, 2017, Jul-01, Volume: 76

    Topics: Drug Delivery Systems; Humans; Hyperthermia, Induced; Nanotubes, Carbon; Neoplasms

2017
The new era of nanotechnology, an alternative to change cancer treatment.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Dendrimers; Drug Delivery Systems; Gold; Humans; Immunotherapy; Liposomes; Metal Nanoparticles; Micr

2017
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Nanotubes, Carbon; Neoplasms

2017
Carbon nanotubes-based drug delivery to cancer and brain.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017, Volume: 37, Issue:5

    Topics: Animals; Blood-Brain Barrier; Central Nervous System Diseases; Drug Delivery Systems; Humans; Nanotu

2017
Carbon Nanotube as a Tool for Fighting Cancer.
    Bioconjugate chemistry, 2018, 03-21, Volume: 29, Issue:3

    Topics: Animals; Antineoplastic Agents; Drug Carriers; Humans; Immunity; Immunologic Factors; Immunomodulati

2018
Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Antineoplastic Agents; Dendrimers; Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Micelles

2017
Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes.
    Molecules (Basel, Switzerland), 2018, Feb-10, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Deoxycytidine; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescent Dyes;

2018
Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer.
    International journal of pharmaceutics, 2018, Sep-05, Volume: 548, Issue:1

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Nanotubes, Carbon; Neoplasms

2018
Advanced Carbon-based Nanoplatforms Combining Drug Delivery and Thermal Therapy for Cancer Treatment.
    Current pharmaceutical design, 2018, Volume: 24, Issue:34

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Nanotubes, Carbon; Neoplasms; Phototh

2018
Carbon Nanotubes as A High-Performance Platform for Target Delivery of Anticancer Quinones.
    Current pharmaceutical design, 2018, Volume: 24, Issue:43

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Drug Delivery Systems; Humans; Nanotubes, Carbon

2018
Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chances.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 03-10, Volume: 297

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Biocompatible Materials; Cancer Vaccines; Ce

2019
State-of-the-Art Preclinical Photoacoustic Imaging in Oncology: Recent Advances in Cancer Theranostics.
    Contrast media & molecular imaging, 2019, Volume: 2019

    Topics: Absorption, Radiation; Animals; Biomarkers, Tumor; Computer Systems; Contrast Media; Early Detection

2019
Recent advances in carbon nanotubes as delivery systems for anticancer drugs.
    Current medicinal chemistry, 2013, Volume: 20, Issue:11

    Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Huma

2013
Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions.
    Chemical Society reviews, 2013, Jun-21, Volume: 42, Issue:12

    Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Carriers; Gene Transfer Techniques; Humans; Nano

2013
Genotoxicity and carcinogenicity risk of carbon nanotubes.
    Advanced drug delivery reviews, 2013, Volume: 65, Issue:15

    Topics: Animals; Asbestos; Carcinogens; Humans; Inhalation Exposure; Mutagenicity Tests; Nanotubes, Carbon;

2013
Carbon nanotubes as vaccine scaffolds.
    Advanced drug delivery reviews, 2013, Volume: 65, Issue:15

    Topics: Animals; Antigen-Presenting Cells; Antigens; Communicable Diseases; Dendritic Cells; Humans; Nanotub

2013
Carbon nanotubes in hyperthermia therapy.
    Advanced drug delivery reviews, 2013, Volume: 65, Issue:15

    Topics: Animals; Humans; Hyperthermia, Induced; Nanotubes, Carbon; Neoplasm Recurrence, Local; Neoplasms; Ti

2013
Carbon nanotubes for delivery of small molecule drugs.
    Advanced drug delivery reviews, 2013, Volume: 65, Issue:15

    Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Drug Design; Humans; Nanotubes

2013
The toxicity and pharmacokinetics of carbon nanotubes as an effective drug carrier.
    Current drug metabolism, 2013, Volume: 14, Issue:8

    Topics: Animals; Drug Carriers; Humans; Laser Therapy; Nanotubes, Carbon; Neoplasms

2013
Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer.
    Journal of nanobiotechnology, 2013, Sep-11, Volume: 11

    Topics: Antigens, Neoplasm; Antigens, Protozoan; B-Lymphocytes; Cancer Vaccines; Drug Delivery Systems; Huma

2013
Carbon-based drug delivery carriers for cancer therapy.
    Archives of pharmacal research, 2014, Volume: 37, Issue:1

    Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Graphite; Humans; Nanodiamonds

2014
Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine.
    Drug metabolism reviews, 2014, Volume: 46, Issue:2

    Topics: Biosensing Techniques; Drug Delivery Systems; Equipment Design; Gene Transfer Techniques; Graphite;

2014
Nanobiosensors: role in cancer detection and diagnosis.
    Advances in experimental medicine and biology, 2014, Volume: 807

    Topics: Biosensing Techniques; Humans; Nanoparticles; Nanotechnology; Nanotubes, Carbon; Neoplasms; Quantum

2014
Nanotubes in biological applications.
    Current opinion in biotechnology, 2014, Volume: 28

    Topics: Antineoplastic Agents; Biosensing Techniques; Cell Culture Techniques; Cell Survival; Drug Carriers;

2014
Advances in nanomedicine towards clinical application in oncology and immunology.
    Current pharmaceutical biotechnology, 2014, Volume: 15, Issue:9

    Topics: Animals; Antineoplastic Agents; Dendrimers; Graphite; Humans; Immunologic Factors; Liposomes; Nanome

2014
Nanotube interactions with microtubules: implications for cancer medicine.
    Nanomedicine (London, England), 2014, Volume: 9, Issue:10

    Topics: Animals; Biomimetic Materials; Drug Design; Humans; Microtubules; Nanotubes, Carbon; Neoplasms

2014
Leukocytes as carriers for targeted cancer drug delivery.
    Expert opinion on drug delivery, 2015, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Drug Carriers; Leukocytes; Liposomes; Metals; Nanoparticles; Nanotubes, Carbo

2015
Anti-cancer cytotoxic effects of multiwalled carbon nanotubes.
    Current pharmaceutical design, 2015, Volume: 21, Issue:15

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Mi

2015
Radio frequency responsive nano-biomaterials for cancer therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Apr-28, Volume: 204

    Topics: Antibodies, Monoclonal; Apoptosis; Catheter Ablation; Ferric Compounds; Gold; Humans; Immunoconjugat

2015
Nanoscale materials for hyperthermal theranostics.
    Nanoscale, 2015, Apr-28, Volume: 7, Issue:16

    Topics: Animals; Diagnostic Imaging; Drug Carriers; Humans; Metal Nanoparticles; Nanostructures; Nanotubes,

2015
Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing.
    Drug discovery today, 2015, Volume: 20, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; H

2015
Carbon nanotubes for cancer therapy and neurodegenerative diseases.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2015, Volume: 56, Issue:2

    Topics: Electric Stimulation; Humans; Microelectrodes; Nanotubes, Carbon; Neoplasms; Neurodegenerative Disea

2015
Carbon Nanomaterials for Drug Delivery and Cancer Therapy.
    Journal of nanoscience and nanotechnology, 2015, Volume: 15, Issue:8

    Topics: Antineoplastic Agents; Carbon; Diffusion; Humans; Nanocapsules; Nanotubes, Carbon; Neoplasms; Partic

2015
Hyperthermia using nanoparticles--Promises and pitfalls.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2016, Volume: 32, Issue:1

    Topics: Animals; Gold; Humans; Hyperthermia, Induced; Magnetic Phenomena; Nanoparticles; Nanotubes, Carbon;

2016
SWCNTs as novel theranostic nanocarriers for cancer diagnosis and therapy: towards safe translation to the clinics.
    Nanomedicine (London, England), 2016, Volume: 11, Issue:11

    Topics: Animals; Antineoplastic Agents; Drug Carriers; Humans; Molecular Targeted Therapy; Multimodal Imagin

2016
Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment.
    Molecules (Basel, Switzerland), 2016, Dec-20, Volume: 21, Issue:12

    Topics: Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Lig

2016
Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment.
    Biosensors, 2017, Feb-15, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Contrast Media; Drug Delivery Systems; Humans; Nanotubes, Carbon; Ne

2017
Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis.
    Drug metabolism reviews, 2017, Volume: 49, Issue:2

    Topics: Animals; Humans; Nanoparticles; Nanotubes, Carbon; Neoplasms; Spectrum Analysis, Raman; Surface Plas

2017
Functionalized single-walled carbon nanotubes: cellular uptake, biodistribution and applications in drug delivery.
    International journal of pharmaceutics, 2017, May-30, Volume: 524, Issue:1-2

    Topics: Cell Membrane; Drug Delivery Systems; Humans; Nanotubes, Carbon; Neoplasms; Tissue Distribution

2017
A review on biomedical applications of single-walled carbon nanotubes.
    Current medicinal chemistry, 2010, Volume: 17, Issue:1

    Topics: Animals; Drug Carriers; Humans; Molecular Imaging; Nanomedicine; Nanotubes, Carbon; Neoplasms; Tissu

2010
Carbon nanotubes in cancer diagnosis and therapy.
    Biochimica et biophysica acta, 2010, Volume: 1806, Issue:1

    Topics: Animals; Drug Delivery Systems; Genetic Therapy; Humans; Hyperthermia, Induced; Lymphatic Metastasis

2010
Functionalized carbon nanotubes for potential medicinal applications.
    Drug discovery today, 2010, Volume: 15, Issue:11-12

    Topics: Animals; Central Nervous System Diseases; Communicable Diseases; Drug Carriers; Drug Delivery System

2010
Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials.
    Archives of biochemistry and biophysics, 2010, Oct-01, Volume: 502, Issue:1

    Topics: Animals; Asbestos; Humans; In Vitro Techniques; Inflammation; Macrophage Activation; Mesothelioma; M

2010
Cancer nanotechnology: application of nanotechnology in cancer therapy.
    Drug discovery today, 2010, Volume: 15, Issue:19-20

    Topics: Dendrimers; Drug Delivery Systems; Drug Design; Genetic Therapy; Humans; Liposomes; Micelles; Nanopa

2010
Recent progress in nanotechnology for cancer therapy.
    Chinese journal of cancer, 2010, Volume: 29, Issue:9

    Topics: Antineoplastic Agents; Dendrimers; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple;

2010
Carbon nanotubes in cancer theragnosis.
    Nanomedicine (London, England), 2010, Volume: 5, Issue:8

    Topics: Antineoplastic Agents; Biocompatible Materials; Biomarkers; DNA, Single-Stranded; Drug Delivery Syst

2010
Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
    Advanced drug delivery reviews, 2011, Volume: 63, Issue:14-15

    Topics: Antineoplastic Agents; Drug Carriers; Drug Compounding; Humans; Molecular Structure; Nanotechnology;

2011
Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel.
    International journal of molecular sciences, 2011, Volume: 12, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Drug Carriers; Humans; Lactic Acid; Magnetite Nanoparticles; Meta

2011
Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Animals; Cell Line, Tumor; Humans; Hyperthermia, Induced; Mice; Nanotubes, Carbon; Neoplasms

2011
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.
    Nanomedicine (London, England), 2011, Volume: 6, Issue:6

    Topics: Animals; Antineoplastic Agents; Humans; Nanomedicine; Nanotubes, Carbon; Neoplasms; Quantum Dots

2011
Diagnostic applications of Raman spectroscopy.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:5

    Topics: Graft Rejection; Humans; Nanotubes, Carbon; Neoplasms; Spectrum Analysis, Raman; Transplantation, Ho

2012
Anticancer platinum (IV) prodrugs with novel modes of activity.
    Current topics in medicinal chemistry, 2011, Volume: 11, Issue:21

    Topics: Antineoplastic Agents; Drug Delivery Systems; Humans; Molecular Targeted Therapy; Nanotubes, Carbon;

2011
Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits?
    Expert review of respiratory medicine, 2011, Volume: 5, Issue:6

    Topics: Animals; Disease Progression; Drug Carriers; Humans; Nanotechnology; Nanotubes, Carbon; Neoplasms; P

2011
Two faces of carbon nanotube: toxicities and pharmaceutical applications.
    Critical reviews in therapeutic drug carrier systems, 2012, Volume: 29, Issue:1

    Topics: Animals; Biocompatible Materials; Biosensing Techniques; Drug Delivery Systems; Gene Transfer Techni

2012
Focused actions to protect carbon nanotube workers.
    American journal of industrial medicine, 2012, Volume: 55, Issue:5

    Topics: Animals; DNA Damage; Humans; Inhalation Exposure; Lung; Nanotubes, Carbon; Neoplasms; Occupational E

2012
Advancement in multifunctional nanoparticles for the effective treatment of cancer.
    Expert opinion on drug delivery, 2012, Volume: 9, Issue:4

    Topics: Biocompatible Materials; Dendrimers; Drug Carriers; Drug Monitoring; Graphite; Humans; Materials Tes

2012
Targeting carbon nanotubes against cancer.
    Chemical communications (Cambridge, England), 2012, Apr-25, Volume: 48, Issue:33

    Topics: Ablation Techniques; Animals; Antineoplastic Agents; Drug Carriers; Humans; Immunotherapy; Nanomedic

2012
Application of nanotechnology in cancer: a review.
    International journal of bioinformatics research and applications, 2012, Volume: 8, Issue:1-2

    Topics: Biosensing Techniques; Drug Delivery Systems; Humans; Nanoparticles; Nanotubes; Nanotubes, Carbon; N

2012
Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes.
    Therapeutic delivery, 2011, Volume: 2, Issue:10

    Topics: Animals; Catheter Ablation; Gold; Humans; Metal Nanoparticles; Nanoparticles; Nanotubes, Carbon; Neo

2011
Near infrared receptor-targeted nanoprobes for early diagnosis of cancers.
    Current medicinal chemistry, 2012, Volume: 19, Issue:28

    Topics: Animals; Early Detection of Cancer; Fluorescent Dyes; Humans; Metal Nanoparticles; Nanoparticles; Na

2012
The upcoming field of theranostic nanomedicine: an overview.
    Journal of biomedical nanotechnology, 2012, Volume: 8, Issue:6

    Topics: Animals; Atherosclerosis; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Genetic T

2012
Glyconanotechnology.
    Chemical Society reviews, 2013, May-21, Volume: 42, Issue:10

    Topics: Biosensing Techniques; Glycomics; Glycoside Hydrolases; Humans; Lectins; Nanoparticles; Nanotechnolo

2013
Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
    Cancer, 2006, Aug-01, Volume: 107, Issue:3

    Topics: Animals; Humans; Nanostructures; Nanotechnology; Nanotubes, Carbon; Neoplasms

2006
What can nanotechnology do to fight cancer?
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:11

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Contrast Media; Diagnostic Imaging; Drug Ca

2006
Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Accounts of chemical research, 2008, Volume: 41, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Biotin; Drug Carriers; Drug Design; Fluorescent Dyes; Humans; Immun

2008
Functionalized carbon nanotubes in drug design and discovery.
    Accounts of chemical research, 2008, Volume: 41, Issue:1

    Topics: Animals; Communicable Diseases; Drug Carriers; Drug Design; Genetic Therapy; Humans; Immunization; N

2008
Carbon nanostructures as a new high-performance platform for MR molecular imaging.
    Advances in experimental medicine and biology, 2007, Volume: 620

    Topics: Carbon; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonan

2007
Carbon fiber-reinforced PEEK spinal implants for primary and metastatic spine tumors: a systematic review on implant complications and radiotherapy benefits.
    Journal of neurosurgery. Spine, 2023, 10-01, Volume: 39, Issue:4

    Topics: Carbon; Carbon Fiber; Humans; Ketones; Kyphosis; Neoplasms; Pedicle Screws; Polyethylene Glycols; Po

2023

Trials

3 trials available for methane and Neoplasms

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp

2023
    Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34

    Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aer

2007

Other Studies

205 other studies available for methane and Neoplasms

ArticleYear
Assessing Residential Exposure Risk from Spills of Flowback Water from Marcellus Shale Hydraulic Fracturing Activity.
    International journal of environmental research and public health, 2018, 04-11, Volume: 15, Issue:4

    Topics: Benzene; Carcinogens; Drinking Water; Environmental Exposure; Humans; Hydraulic Fracking; Inhalation

2018
Shale gas development and cancer incidence in southwest Pennsylvania.
    Public health, 2016, Volume: 141

    Topics: Extraction and Processing Industry; Female; Humans; Incidence; Leukemia; Male; Natural Gas; Neoplasm

2016
Human health risk assessment of air emissions from development of unconventional natural gas resources.
    The Science of the total environment, 2012, May-01, Volume: 424

    Topics: Air Pollutants; Air Pollution; Colorado; Environmental Exposure; Environmental Monitoring; Epidemiol

2012
    Molecules (Basel, Switzerland), 2021, Sep-12, Volume: 26, Issue:18

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Screening Assays, A

2021
A Green Synthesis of Carbene-Metal-Amides (CMAs) and Carboline-Derived CMAs with Potent in vitro and ex vivo Anticancer Activity.
    ChemMedChem, 2022, 07-05, Volume: 17, Issue:13

    Topics: Amides; Carbolines; Heterocyclic Compounds; Humans; Ligands; Metals; Methane; Molecular Structure; N

2022
Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2019, Oct-09, Volume: 18, Issue:10

    Topics: Anti-Infective Agents; Boron Compounds; Cell Line, Tumor; Cell Survival; Coordination Complexes; Hum

2019
Photochemical Reactions in the Synthesis of Protein-Drug Conjugates.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2020, Jan-02, Volume: 26, Issue:1

    Topics: Animals; Antibodies; Cell Line, Tumor; Copper Radioisotopes; Cycloaddition Reaction; Humans; Isotope

2020
Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.
    Journal of inorganic biochemistry, 2020, Volume: 202

    Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; G-Quadruplexes; Humans; Ligands; MCF-7 Cell

2020
    Molecules (Basel, Switzerland), 2020, Jul-09, Volume: 25, Issue:14

    Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Methane; Neoplasms; N

2020
Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer.
    Journal of the American Chemical Society, 2020, 12-09, Volume: 142, Issue:49

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Endoplasmic Reticulum Stre

2020
Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in vitro and ex vivo Study.
    ChemMedChem, 2017, 09-07, Volume: 12, Issue:17

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Heterocyclic Compounds; Humans; Kidney; Male; Meth

2017
Synthesis of novel antiproliferative hybrid bis-(3-indolyl)methane phosphonate derivatives.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Methane; Neoplasms; Or

2018
Fluorescent functionalised naphthalimides and their Au(i)-NHC complexes for potential use in cellular bioimaging.
    Dalton transactions (Cambridge, England : 2003), 2019, Feb-07, Volume: 48, Issue:5

    Topics: Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Fluorescent Dyes; Gold; Heterocy

2019
Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy.
    Biomaterials, 2019, Volume: 217

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Chickens; Doxorubicin; Drug Delivery Systems; Drug Li

2019
Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights.
    Metallomics : integrated biometal science, 2013, Volume: 5, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Survival; Cytosol; Dimerization; Drug Screening Assays, Antitumor; G

2013
Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes.
    Journal of inorganic biochemistry, 2013, Volume: 129

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Heterocyclic Compounds, 1-Ring; Humans;

2013
Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene-gold(I) complex.
    Metallomics : integrated biometal science, 2014, Volume: 6, Issue:9

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Gold; H

2014
Luminescent platinum(II) complexes with functionalized N-heterocyclic carbene or diphosphine selectively probe mismatched and abasic DNA.
    Nature communications, 2016, Feb-17, Volume: 7

    Topics: Base Pair Mismatch; Biosensing Techniques; DNA; Humans; Luminescence; Methane; Neoplasms; Platinum

2016
Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression.
    Angewandte Chemie (International ed. in English), 2016, 09-19, Volume: 55, Issue:39

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Co

2016
A platinum Chugaev carbene complex as a potent anticancer agent.
    Chemical communications (Cambridge, England), 2011, Jul-21, Volume: 47, Issue:27

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; DNA, Superhelical; H

2011
Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities.
    Journal of inorganic biochemistry, 2012, Volume: 106, Issue:1

    Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Line, Tumor; Cell Survival; Cells, Cultured;

2012
FURTHER ASPECTS OF LYMPHOSARCOMA IN XENOPUS (THE SOUTH AFRICAN CLAWED TOAD).
    Cancer research, 1965, Volume: 25

    Topics: Animals; Anura; Carcinogens; Lymphoma; Lymphoma, Non-Hodgkin; Metamorphosis, Biological; Methane; Ne

1965
1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors.
    Magnetic resonance in medicine, 1989, Volume: 9, Issue:1

    Topics: Adult; Female; Humans; Hydrogen; Infant, Newborn; Lactates; Lipoproteins; Magnetic Resonance Spectro

1989
[Implication of hydroxyl radical production in the killing of tumor cells by recombinant human tumor necrosis factor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:10

    Topics: Cell Line; Cell Survival; Dimethyl Sulfoxide; Fibroblasts; Humans; Hydroxides; Hydroxyl Radical; Met

1988
Systematic Patent Review of Nanoparticles in Drug Delivery and Cancer Therapy in the Last Decade.
    Recent advances in drug delivery and formulation, 2021, Volume: 15, Issue:1

    Topics: Drug Delivery Systems; Nanomedicine; Nanoparticles; Nanotubes, Carbon; Neoplasms; Pharmaceutical Pre

2021
π-π conjugation promoted nanocatalysis for cancer therapy based on a covalent organic framework.
    Materials horizons, 2021, 11-29, Volume: 8, Issue:12

    Topics: Animals; Metal-Organic Frameworks; Mice; Nanoparticles; Nanotubes, Carbon; Neoplasms; Photochemother

2021
Bioinspired Electron Polarization of Nanozymes with a Human Self-Generated Electric Field for Cancer Catalytic Therapy.
    Advanced materials (Deerfield Beach, Fla.), 2022, Volume: 34, Issue:15

    Topics: Animals; Catalysis; Electrons; Humans; Mice; Nanotubes, Carbon; Neoplasms; Reactive Oxygen Species

2022
An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1.
    Biosensors & bioelectronics, 2022, Jul-01, Volume: 207

    Topics: Animals; B7-H1 Antigen; Biosensing Techniques; Humans; Immune Checkpoint Proteins; Immunotherapy; Mi

2022
pH-sensitive carbon nanotubes graft polymethylacrylic acid self-assembly nanoplatforms for cellular drug release.
    Journal of biomaterials applications, 2022, Volume: 37, Issue:4

    Topics: Antineoplastic Agents; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Micelles;

2022
Potential of novel self-assembled functionalized carbon nanotubes for selective tumor targeting.
    Pharmaceutical patent analyst, 2022, Volume: 11, Issue:3

    Topics: Humans; Nanotubes, Carbon; Neoplasms

2022
Fullerene Derivatives (C
    International journal of molecular sciences, 2022, Aug-25, Volume: 23, Issue:17

    Topics: Antineoplastic Agents; Doxorubicin; Fullerenes; Hydroxides; Nanotubes, Carbon; Neoplasms; Pharmaceut

2022
Single-Site Fe-N-C Atom Based Carbon Nanotubes for Mutually Promoted and Synergistic Oncotherapy.
    ACS applied materials & interfaces, 2022, Nov-02, Volume: 14, Issue:43

    Topics: Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Liberation; Female; Humans; Hydrogen Peroxide;

2022
Competitive electrochemical sensing for cancer cell evaluation based on thionine-interlinked signal probes.
    The Analyst, 2023, Feb-13, Volume: 148, Issue:4

    Topics: Biosensing Techniques; Electrochemical Techniques; Gold; Limit of Detection; Mannose; Nanotubes, Car

2023
Duplex Phenotype Detection and Targeting of Breast Cancer Cells Using Nanotube Nanoprobes and Raman Imaging.
    ACS applied bio materials, 2023, 03-20, Volume: 6, Issue:3

    Topics: Antibodies; Biomarkers; Nanotubes, Carbon; Neoplasms; Phenotype; Polyethylene Glycols; Reproducibili

2023
Synthesis of single-walled carbon nanotubes functionalized with platinum nanoparticles to sense breast cancer cells in 4T1 model to X-ray radiation.
    Mikrochimica acta, 2023, 04-18, Volume: 190, Issue:5

    Topics: Animals; Cell Line; Metal Nanoparticles; Mice; Nanotubes, Carbon; Neoplasms; Platinum; Serum Albumin

2023
Adoptive transfer of Fe
    Colloids and surfaces. B, Biointerfaces, 2023, Volume: 229

    Topics: Adoptive Transfer; Humans; Immunotherapy; Macrophages; Nanotubes, Carbon; Neoplasms; Tumor Microenvi

2023
Inhalation of multi-wall carbon nanotubes changes the expression of apoptosis and cancer genes in rat brain and lungs.
    Bratislavske lekarske listy, 2023, Volume: 124, Issue:9

    Topics: Animals; Apoptosis; Brain; Genes, Neoplasm; Lung; Nanotubes, Carbon; Neoplasms; Rats

2023
Nitric Oxide Detection Using a Corona Phase Molecular Recognition Site on Chiral Single-Walled Carbon Nanotubes.
    ACS applied bio materials, 2023, 11-20, Volume: 6, Issue:11

    Topics: DNA; Humans; Nanotubes, Carbon; Neoplasms; Nitric Oxide; Polymers

2023
Carbon nanotube based dielectric spectroscopy of tumor secretion; electrochemical lipidomics for cancer diagnosis.
    Biosensors & bioelectronics, 2019, Oct-01, Volume: 142

    Topics: Cell Line, Tumor; Dielectric Spectroscopy; Equipment Design; Humans; Lipid Metabolism; Lipidomics; N

2019
Electrochemical generation of microbubbles by carbon nanotube interdigital electrodes to increase the permeability and material uptakes of cancer cells.
    Drug delivery, 2019, Volume: 26, Issue:1

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Electrodes; Humans; Micr

2019
Functionalized helical fibre bundles of carbon nanotubes as electrochemical sensors for long-term in vivo monitoring of multiple disease biomarkers.
    Nature biomedical engineering, 2020, Volume: 4, Issue:2

    Topics: Animals; Biocompatible Materials; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Cats; Diabet

2020
pH-sensitive loading/releasing of doxorubicin using single-walled carbon nanotube and multi-walled carbon nanotube: A molecular dynamics study.
    Computer methods and programs in biomedicine, 2020, Volume: 186

    Topics: Adsorption; Antibiotics, Antineoplastic; Doxorubicin; Drug Carriers; Humans; Hydrogen-Ion Concentrat

2020
Interfacial Nanoparticle Complexation of Oppositely Charged Nanocelluloses into Functional Filaments with Conductive, Drug Release, or Antimicrobial Property.
    ACS applied materials & interfaces, 2020, Jan-08, Volume: 12, Issue:1

    Topics: Anti-Infective Agents; Antineoplastic Agents; Doxorubicin; Drug Delivery Systems; Drug Liberation; E

2020
Carbon nanotubes added to the SIN List as a nanomaterial of Very High Concern.
    Nature nanotechnology, 2020, Volume: 15, Issue:1

    Topics: Animals; Carcinogens; Humans; Nanotechnology; Nanotubes, Carbon; Neoplasms; Reproduction

2020
Simulation of Carbon Nanotube-Based Enhancement of Cellular Electroporation under Nanosecond Pulsed Electric Fields.
    BioMed research international, 2019, Volume: 2019

    Topics: Cell Membrane; Electricity; Electromagnetic Fields; Electroporation; Humans; Nanotubes, Carbon; Neop

2019
Cancer Therapy and Imaging Through Functionalized Carbon Nanotubes Decorated with Magnetite and Gold Nanoparticles as a Multimodal Tool.
    Applied biochemistry and biotechnology, 2020, Volume: 191, Issue:3

    Topics: Contrast Media; Ferrosoferric Oxide; Gold; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging

2020
Fluorescent hollow mesoporous carbon spheres for drug loading and tumor treatment through 980-nm laser and microwave co-irradiation.
    Biomaterials, 2020, Volume: 248

    Topics: Animals; Lasers; Mice; Microwaves; Nanoparticles; Nanotubes, Carbon; Neoplasms; Pharmaceutical Prepa

2020
A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy.
    Journal of materials chemistry. B, 2020, 09-23, Volume: 8, Issue:36

    Topics: Animals; Catalysis; Chlorophyllides; Female; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Inf

2020
Aqueous Suspensions of Cellulose Oligomer Nanoribbons for Growth and Natural Filtration-Based Separation of Cancer Spheroids.
    Langmuir : the ACS journal of surfaces and colloids, 2020, 11-24, Volume: 36, Issue:46

    Topics: Cell Culture Techniques; Cellulose; Nanotubes, Carbon; Neoplasms; Spheroids, Cellular; Suspensions

2020
Single-walled carbon nanotubes as a photo-thermo-acoustic cancer theranostic agent: theory and proof of the concept experiment.
    Scientific reports, 2020, 12-17, Volume: 10, Issue:1

    Topics: Animals; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Humans; Models, Theoretical; Nano

2020
Nanoparticles Incorporating a Fluorescence Turn-on Reporter for Real-Time Drug Release Monitoring, a Chemoenhancer and a Stealth Agent: Poseidon's Trident against Cancer?
    Molecular pharmaceutics, 2021, 01-04, Volume: 18, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Deliver

2021
Label-Free Electrochemical Immunosensor for Ultrasensitive Detection of Carbohydrate Antigen 125 Based on Antibody-Immobilized Biocompatible MOF-808/CNT.
    ACS applied materials & interfaces, 2021, Jan-20, Volume: 13, Issue:2

    Topics: Antibodies, Immobilized; Biosensing Techniques; CA-125 Antigen; Electrochemical Techniques; Electrod

2021
An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood.
    Communications biology, 2021, 01-26, Volume: 4, Issue:1

    Topics: Biomarkers, Tumor; Biosensing Techniques; Blood Chemical Analysis; Early Detection of Cancer; Electr

2021
The design and fabrication of nanoengineered platinum needles with laser welded carbon nanotubes (CNTs) for the electrochemical biosensing of cancer lymph nodes.
    Biomaterials science, 2021, Sep-14, Volume: 9, Issue:18

    Topics: Animals; Biosensing Techniques; Electrochemical Techniques; Electrodes; Lasers; Lymph Nodes; Nanotub

2021
Facile construction of mitochondria-targeting nanoparticles for enhanced phototherapeutic effects.
    Biomaterials science, 2017, May-02, Volume: 5, Issue:5

    Topics: Cell Survival; Drug Delivery Systems; HeLa Cells; Humans; Indocyanine Green; Mitochondria; Nanoparti

2017
Ultrasensitive Label-Free Sensing of IL-6 Based on PASE Functionalized Carbon Nanotube Micro-Arrays with RNA-Aptamers as Molecular Recognition Elements.
    Biosensors, 2017, Apr-17, Volume: 7, Issue:2

    Topics: Animals; Aptamers, Nucleotide; Biomarkers, Tumor; Cattle; Female; Humans; Interleukin-6; Male; Nanot

2017
Synergistic Suppression of Tumor Angiogenesis by the Co-delivering of Vascular Endothelial Growth Factor Targeted siRNA and Candesartan Mediated by Functionalized Carbon Nanovectors.
    ACS applied materials & interfaces, 2017, Jul-19, Volume: 9, Issue:28

    Topics: Animals; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Humans; Mice; Mice, Nude; Nanotubes,

2017
An innovative MWCNTs/DOX/TC nanosystem for chemo-photothermal combination therapy of cancer.
    Nanomedicine : nanotechnology, biology, and medicine, 2017, Volume: 13, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Combined Modality Therapy; Doxorub

2017
Size of single-wall carbon nanotube affects the folate receptor-mediated cancer cell targeting.
    Biotechnology and applied biochemistry, 2018, Volume: 65, Issue:3

    Topics: Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Folate Receptors, GPI-Anchor

2018
SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
    Scientific reports, 2017, 09-14, Volume: 7, Issue:1

    Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Diseas

2017
Integrating photoluminescence, magnetism and thermal conversion for potential photothermal therapy and dual-modal bioimaging.
    Journal of colloid and interface science, 2018, Jan-15, Volume: 510

    Topics: Cell Survival; Fluorescent Dyes; HeLa Cells; Humans; Lanthanoid Series Elements; Light; Luminescence

2018
Facile Preparation of Doxorubicin-Loaded and Folic Acid-Conjugated Carbon Nanotubes@Poly(N-vinyl pyrrole) for Targeted Synergistic Chemo-Photothermal Cancer Treatment.
    Bioconjugate chemistry, 2017, 11-15, Volume: 28, Issue:11

    Topics: Antibiotics, Antineoplastic; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cel

2017
Peptide and peptide-carbon nanotube hydrogels as scaffolds for tissue & 3D tumor engineering.
    Acta biomaterialia, 2018, 03-15, Volume: 69

    Topics: A549 Cells; Animals; Humans; Hydrogels; Mice; Nanotubes, Carbon; Neoplasms; NIH 3T3 Cells; Peptides;

2018
PEGylated multi-walled carbon nanotubes as versatile vector for tumor-specific intracellular triggered release with enhanced anti-cancer efficiency: Optimization of length and PEGylation degree.
    Colloids and surfaces. B, Biointerfaces, 2018, Aug-01, Volume: 168

    Topics: Antibiotics, Antineoplastic; Cell Survival; Doxorubicin; Drug Delivery Systems; Drug Liberation; Hep

2018
Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel.
    International journal of pharmaceutics, 2018, May-30, Volume: 543, Issue:1-2

    Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Survival; Chitosan; Docetaxel; Drug Carriers; Drug

2018
Covalent functionalization of SWCNT with combretastatin A4 for cancer therapy.
    Nanotechnology, 2018, Jun-15, Volume: 29, Issue:24

    Topics: Apoptosis; Cell Cycle; Cell Survival; Click Chemistry; Drug Liberation; HeLa Cells; Humans; Nanotube

2018
An Immunologically Modified Nanosystem Based on Noncovalent Binding Between Single-Walled Carbon Nanotubes and Glycated Chitosan.
    Technology in cancer research & treatment, 2018, 01-01, Volume: 17

    Topics: Chitosan; Drug Delivery Systems; Humans; Molecular Dynamics Simulation; Nanotubes, Carbon; Neoplasms

2018
Abnormal Anionic Porphyrin Sensing Effect for HER2 Gene Related DNA Detection via Impedance Difference between MWCNTs and Single-Stranded DNA or Double-Stranded DNA.
    Molecules (Basel, Switzerland), 2018, Oct-18, Volume: 23, Issue:10

    Topics: Anions; Biosensing Techniques; Dielectric Spectroscopy; DNA, Single-Stranded; Humans; Limit of Detec

2018
Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors.
    Drug delivery, 2018, Volume: 25, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; D

2018
SWCNTs@GQDs composites as nanocarriers for enzyme-free dual-signal amplification electrochemical immunoassay of cancer biomarker.
    Analytica chimica acta, 2018, Dec-26, Volume: 1042

    Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Electrochemical Techniques; Graphite; Immunoassay; Nano

2018
Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
    Colloids and surfaces. B, Biointerfaces, 2019, Jan-01, Volume: 173

    Topics: Animals; Antineoplastic Agents; Carbon; Cell Survival; Colloids; Drug Delivery Systems; Ferric Compo

2019
Chemical reactivity and adsorption properties of pro-carbazine anti-cancer drug on gallium-doped nanotubes: a quantum chemical study.
    Journal of molecular modeling, 2019, Jan-28, Volume: 25, Issue:2

    Topics: Adsorption; Algorithms; Antineoplastic Agents; Binding Sites; Computer Simulation; Drug Delivery Sys

2019
Mild Hyperthermia-Enhanced Enzyme-Mediated Tumor Cell Chemodynamic Therapy.
    ACS applied materials & interfaces, 2019, Jul-03, Volume: 11, Issue:26

    Topics: Glucose; Humans; Hydrogen Peroxide; Hydroxyl Radical; Hypothermia, Induced; Nanoparticles; Nanotubes

2019
Single-cell resolution diagnosis of cancer cells by carbon nanotube electrical spectroscopy.
    Nanoscale, 2013, Apr-21, Volume: 5, Issue:8

    Topics: Biosensing Techniques; Breast Neoplasms; Colonic Neoplasms; Dielectric Spectroscopy; Female; HT29 Ce

2013
Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells.
    Journal of drug targeting, 2013, Volume: 21, Issue:6

    Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Fo

2013
Endowing carbon nanotubes with superparamagnetic properties: applications for cell labeling, MRI cell tracking and magnetic manipulations.
    Nanoscale, 2013, May-21, Volume: 5, Issue:10

    Topics: Cell Line, Tumor; Click Chemistry; Contrast Media; Humans; Magnetic Phenomena; Magnetic Resonance Im

2013
Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of Doxorubicin to cancer cells.
    Macromolecular bioscience, 2013, Volume: 13, Issue:6

    Topics: 3T3 Cells; Animals; Biocompatible Materials; Cell Death; Cell Survival; Doxorubicin; Drug Delivery S

2013
Detection and discrimination of alpha-fetoprotein with a label-free electrochemical impedance spectroscopy biosensor array based on lectin functionalized carbon nanotubes.
    Talanta, 2013, Jul-15, Volume: 111

    Topics: alpha-Fetoproteins; Biosensing Techniques; Dielectric Spectroscopy; Electrodes; Humans; Lectins; Lim

2013
A novel nanoprobe based on single-walled carbon nanotubes/photosensitizer for cancer cell imaging and therapy.
    Journal of nanoscience and nanotechnology, 2013, Volume: 13, Issue:2

    Topics: Humans; Nanotubes, Carbon; Neoplasms; Photosensitizing Agents; Tumor Cells, Cultured

2013
Synthesis and characterization of superparamagnetic CoFe2O4/MWCNT hybrids for tumor-targeted therapy.
    Journal of nanoscience and nanotechnology, 2013, Volume: 13, Issue:1

    Topics: Animals; Cobalt; Ferric Compounds; Humans; Macromolecular Substances; Magnetite Nanoparticles; Mater

2013
Single-walled carbon nanotubes mediated neovascularity targeted antitumor drug delivery system.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2013, Volume: 16, Issue:1

    Topics: 2-Methoxyestradiol; Animals; Cell Line, Tumor; Drug Delivery Systems; Estradiol; Female; Humans; MCF

2013
DNA interaction of [Cu(dmp)(phen-dion)] (dmp=4,7 and 2,9 dimethyl phenanthroline, phen-dion=1,10-phenanthroline-5,6-dion) complexes and DNA-based electrochemical biosensor using chitosan-carbon nanotubes composite film.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Volume: 114

    Topics: Antineoplastic Agents; Biosensing Techniques; Cell Line, Tumor; Cell Survival; Chitosan; Coordinatio

2013
Graphene oxide protected nucleic acid probes for bioanalysis and biomedicine.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2013, Aug-05, Volume: 19, Issue:32

    Topics: Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Doxorubicin; Drug Carriers; Gene Transfer Te

2013
Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug.
    ACS nano, 2013, Oct-22, Volume: 7, Issue:10

    Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Dose-Response Relationship,

2013
Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery.
    Nature nanotechnology, 2013, Volume: 8, Issue:10

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Delivery Systems; Mice; Morpholinos; Nanotub

2013
Photothermal ablation of tumor cells using a single-walled carbon nanotube-peptide composite.
    Journal of controlled release : official journal of the Controlled Release Society, 2014, Jan-10, Volume: 173

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Line, Tumor; Hep G2 Cells; Humans; Hyperth

2014
Carbon nanotube sensors could aid drug manufacturing.
    Future medicinal chemistry, 2013, Volume: 5, Issue:15

    Topics: Antibodies; Biosensing Techniques; Drug Industry; Humans; Nanotubes, Carbon; Neoplasm Proteins; Neop

2013
Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?
    Therapeutic delivery, 2014, Volume: 5, Issue:1

    Topics: Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Humans; Nanotechnology; Nanotubes, Carb

2014
Highly enhanced electrochemiluminescent strategy for tumor biomarkers detection with in situ generation of L-homocysteine for signal amplification.
    Analytica chimica acta, 2014, Mar-07, Volume: 815

    Topics: Adenosylhomocysteinase; Biomarkers, Tumor; Electrochemical Techniques; Enzymes, Immobilized; Gold; G

2014
A novel impedimetric disposable immunosensor for rapid detection of a potential cancer biomarker.
    International journal of biological macromolecules, 2014, Volume: 66

    Topics: Antibodies, Immobilized; Biomarkers, Tumor; Biosensing Techniques; Dielectric Spectroscopy; Disposab

2014
Golden single-walled carbon nanotubes prepared using double layer polysaccharides bridge for photothermal therapy.
    ACS applied materials & interfaces, 2014, Apr-09, Volume: 6, Issue:7

    Topics: Cell Line, Tumor; Cell Survival; Gold; HeLa Cells; Humans; Hyperthermia, Induced; Infrared Rays; Nan

2014
The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
    Biomaterials, 2014, Volume: 35, Issue:15

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans;

2014
Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.
    ACS nano, 2014, May-27, Volume: 8, Issue:5

    Topics: Animals; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resist

2014
Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells.
    Journal of biomedical nanotechnology, 2014, Volume: 10, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitin; Drug Carriers; Drug Evaluation, Prec

2014
Transplanted tumor growth inhibition by functionalized short single-walled carbon nanotubules.
    Bulletin of experimental biology and medicine, 2014, Volume: 156, Issue:3

    Topics: Animals; Cell Division; Heterografts; Humans; Nanotubes, Carbon; Neoplasms; Rats

2014
A carbon nanotube-based Raman-imaging immunoassay for evaluating tumor targeting ligands.
    The Analyst, 2014, Jun-21, Volume: 139, Issue:12

    Topics: Cell Line, Tumor; Fluorescent Antibody Technique; Humans; Immunoassay; Ligands; Microscopy, Atomic F

2014
Mesoscopic modeling of cancer photothermal therapy using single-walled carbon nanotubes and near infrared radiation: insights through an off-lattice Monte Carlo approach.
    Nanotechnology, 2014, May-23, Volume: 25, Issue:20

    Topics: Computer Simulation; Humans; Hyperthermia, Induced; Infrared Rays; Monte Carlo Method; Nanotubes, Ca

2014
DNA impedance biosensor for detection of cancer, TP53 gene mutation, based on gold nanoparticles/aligned carbon nanotubes modified electrode.
    Analytica chimica acta, 2014, Jul-11, Volume: 836

    Topics: Biosensing Techniques; Dielectric Spectroscopy; DNA Mutational Analysis; DNA Probes; Electrochemical

2014
One-pot synthesis and functionalisation of Fe2O3@C-NH2 nanoparticles for imaging and therapy.
    IET nanobiotechnology, 2014, Volume: 8, Issue:2

    Topics: Amines; Catalysis; Cell Line, Tumor; Ferric Compounds; Folic Acid; Hot Temperature; Humans; Hydrogen

2014
Ultrastructural localization of intravenously injected carbon nanohorns in tumor.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Animals; Antineoplastic Agents; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Nano

2014
Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8(+) T cell response and protection against cancer.
    Nano letters, 2014, Sep-10, Volume: 14, Issue:9

    Topics: Animals; Anticarcinogenic Agents; Antigens; Antigens, Neoplasm; Calibration; Cancer Vaccines; CD4-Po

2014
A versatile activatable fluorescence probing platform for cancer cells in vitro and in vivo based on self-assembled aptamer/carbon nanotube ensembles.
    Analytical chemistry, 2014, Sep-16, Volume: 86, Issue:18

    Topics: Animals; Aptamers, Nucleotide; Carbocyanines; Cell Line, Tumor; Flow Cytometry; Fluorescent Dyes; Hu

2014
pH-Responsive single walled carbon nanotube dispersion for target specific release of doxorubicin to cancer cells.
    Macromolecular bioscience, 2014, Volume: 14, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; CHO Cells; Cricetinae; Cricetulus; Doxorubicin; Drug Carriers;

2014
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-23, Volume: 111, Issue:38

    Topics: Animals; Bacteriophage M13; Cell Line, Tumor; Contrast Media; Drug Delivery Systems; Fluorescent Dye

2014
Sensitive detection of tumor cells by a new cytosensor with 3D-MWCNTs array based on vicinal-dithiol-containing proteins (VDPs).
    Biosensors & bioelectronics, 2015, Apr-15, Volume: 66

    Topics: Aniline Compounds; Arsenicals; Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques;

2015
Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes.
    The Lancet. Oncology, 2014, Volume: 15, Issue:13

    Topics: Asbestos, Amphibole; Biocompatible Materials; Carbon Compounds, Inorganic; Cell Transformation, Neop

2014
Nanovectorization of TRAIL with single wall carbon nanotubes enhances tumor cell killing.
    Nano letters, 2015, Feb-11, Volume: 15, Issue:2

    Topics: Cell Line, Tumor; Humans; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasms; Receptor

2015
Preferential magnetic targeting of carbon nanotubes to cancer sites: noninvasive tracking using MRI in a murine breast cancer model.
    Nanomedicine (London, England), 2015, Volume: 10, Issue:6

    Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Diffusion; Drug Carriers; Endogli

2015
Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes.
    Colloids and surfaces. B, Biointerfaces, 2015, Aug-01, Volume: 132

    Topics: Animals; Cell Line, Tumor; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Microscopy, Atomic Force;

2015
Inhibition of Cancer Cell Migration by Multiwalled Carbon Nanotubes.
    Advanced healthcare materials, 2015, Aug-05, Volume: 4, Issue:11

    Topics: Biocompatible Materials; Cell Line, Tumor; Cell Movement; Cell Proliferation; HeLa Cells; Humans; MC

2015
Carbohydrate derivative-functionalized biosensing toward highly sensitive electrochemical detection of cell surface glycan expression as cancer biomarker.
    Biosensors & bioelectronics, 2015, Dec-15, Volume: 74

    Topics: Biomarkers, Tumor; Biosensing Techniques; Cell Line, Tumor; Electrochemical Techniques; Gold; Humans

2015
A novel single walled carbon nanotube (SWCNT) functionalization agent facilitating in vivo combined chemo/thermo therapy.
    Nanoscale, 2015, Oct-21, Volume: 7, Issue:39

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Hot Temperature; Humans; Nanotubes, Carbon;

2015
pH-sensitive nanocarrier based on gold/silver core-shell nanoparticles decorated multi-walled carbon manotubes for tracing drug release in living cells.
    Biosensors & bioelectronics, 2016, Jan-15, Volume: 75

    Topics: Biosensing Techniques; Cell Line, Tumor; Doxorubicin; Drug Liberation; Fluorescein-5-isothiocyanate;

2016
pH Responsive Release of Doxorubicin to the Cancer Cells by Functionalized Multi-Walled Carbon Nanotubes.
    Journal of nanoscience and nanotechnology, 2015, Volume: 15, Issue:7

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Humans; Hyd

2015
Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugs.
    Scientific reports, 2015, Oct-20, Volume: 5

    Topics: Animals; Antineoplastic Agents; Biological Transport; Disease Models, Animal; Doxorubicin; Drug Carr

2015
Microwave pumped high-efficient thermoacoustic tumor therapy with single wall carbon nanotubes.
    Biomaterials, 2016, Volume: 75

    Topics: Acoustics; Animals; Cell Line, Tumor; Female; Hyperthermia, Induced; Mice, Inbred BALB C; Microwaves

2016
State Estimation of the Time-Varying and Spatially Localized Concentration of Signal Molecules from the Stochastic Adsorption Dynamics on the Carbon Nanotube-Based Sensors and Its Application to Tumor Cell Detection.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Animals; Biosensing Techniques; Humans; Models, Biological; Nanotubes, Carbon; Neoplasms; Stochastic

2015
Design of antibody-functionalized carbon nanotubes filled with radioactivable metals towards a targeted anticancer therapy.
    Nanoscale, 2016, Jul-07, Volume: 8, Issue:25

    Topics: Animals; Cell Line, Tumor; Cetuximab; CHO Cells; Cricetulus; ErbB Receptors; Humans; Metals; Nanotub

2016
Combining the single-walled carbon nanotubes with low voltage electrical stimulation to improve accumulation of nanomedicines in tumor for effective cancer therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, Mar-10, Volume: 225

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Electric Stimulation; Female; HT29 Cel

2016
Near-Infrared Light Activation of Proteins Inside Living Cells Enabled by Carbon Nanotube-Mediated Intracellular Delivery.
    ACS applied materials & interfaces, 2016, Volume: 8, Issue:7

    Topics: Animals; Biotin; Cell Line, Tumor; Cytoplasm; Drug Delivery Systems; Green Fluorescent Proteins; HeL

2016
Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy.
    ACS applied materials & interfaces, 2016, Mar-02, Volume: 8, Issue:8

    Topics: Animals; Humans; Hyaluronan Receptors; Hyaluronic Acid; Indocyanine Green; Mice; Nanoparticles; Nano

2016
Design and development of PCR-free highly sensitive electrochemical assay for detection of telomerase activity using Nano-based (liposomal) signal amplification platform.
    Biosensors & bioelectronics, 2016, Jun-15, Volume: 80

    Topics: Biomarkers, Tumor; Biosensing Techniques; HeLa Cells; Humans; Liposomes; Nanotubes, Carbon; Neoplasm

2016
In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.
    Materials science & engineering. C, Materials for biological applications, 2016, Volume: 62

    Topics: Animals; Antimetabolites, Antineoplastic; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell

2016
Gold Nanoparticle Coated Carbon Nanotube Ring with Enhanced Raman Scattering and Photothermal Conversion Property for Theranostic Applications.
    Journal of the American Chemical Society, 2016, 06-08, Volume: 138, Issue:22

    Topics: Animals; Cell Line, Tumor; Electromagnetic Fields; Gold; Hyperthermia, Induced; Metal Nanoparticles;

2016
Polydopamine Coated Single-Walled Carbon Nanotubes as a Versatile Platform with Radionuclide Labeling for Multimodal Tumor Imaging and Therapy.
    Theranostics, 2016, Volume: 6, Issue:11

    Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Combined Modality Therapy; Female; Indoles; Iodi

2016
Fabrication of mediator-free hybrid nano-interfaced electrochemical biosensor for monitoring cancer cell proliferation.
    Biosensors & bioelectronics, 2017, Jan-15, Volume: 87

    Topics: Biosensing Techniques; Cell Line, Tumor; Cell Proliferation; Electrochemical Techniques; Enzymes, Im

2017
Evaluations of the Carcinogenicity of Carbon Nanotubes, Fluoro-Edinite, and Silicon Carbide by the International Agency for Research on Cancer (IARC).
    Nihon eiseigaku zasshi. Japanese journal of hygiene, 2016, Volume: 71, Issue:3

    Topics: Animals; Asbestos, Amphibole; Carbon Compounds, Inorganic; Carcinogens, Environmental; Environmental

2016
An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Nov-15, Volume: 1036-1037

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Humans; Immobilize

2016
Development of screen-printed tryptophan-kynurenine immunosensor for in vitro assay of kynurenine-mediated immunosuppression effect of cancer cells on activated T-cells.
    Biosensors & bioelectronics, 2017, Jun-15, Volume: 92

    Topics: Antibodies, Immobilized; Biosensing Techniques; Cell Line, Tumor; Electrodes; Equipment Design; Gold

2017
Next-generation nanotech meds: Diagnostic and therapeutic applications of non-organic nanoparticles are making their way into clinical use.
    EMBO reports, 2017, Volume: 18, Issue:1

    Topics: Antineoplastic Agents; Bone and Bones; Humans; Molecular Imaging; Nanoparticles; Nanotechnology; Nan

2017
Graphene quantum dots for cancer targeted drug delivery.
    International journal of pharmaceutics, 2017, Feb-25, Volume: 518, Issue:1-2

    Topics: A549 Cells; Antibiotics, Antineoplastic; Biotin; Cell Survival; Doxorubicin; Drug Delivery Systems;

2017
Comparative binding to DR4 and DR5 receptors of TRAIL and BNNTs/PAHE/mPEG-DSPE/TRAIL nanoparticles.
    Journal of molecular recognition : JMR, 2017, Volume: 30, Issue:7

    Topics: Cell Line, Tumor; Humans; Nanotubes, Carbon; Neoplasms; Protein Binding; Pyrenes; Receptors, TNF-Rel

2017
Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment.
    Drug metabolism reviews, 2017, Volume: 49, Issue:2

    Topics: Animals; Humans; Nanoparticles; Nanotubes, Carbon; Neoplasms; Spectrum Analysis, Raman; Surface Plas

2017
Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy.
    Nanomedicine (London, England), 2008, Volume: 3, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prolife

2008
Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy.
    Small (Weinheim an der Bergstrasse, Germany), 2008, Volume: 4, Issue:9

    Topics: Animals; Cell Line, Tumor; Immunotherapy; Mice; Microscopy, Electron; Nanotubes, Carbon; Neoplasm Tr

2008
Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-30, Volume: 105, Issue:39

    Topics: Animals; Cell Line, Tumor; Humans; Hyperthermia, Induced; Indoles; Isoindoles; Lasers; Materials Tes

2008
Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2008, Volume: 24, Issue:6

    Topics: Animals; Biosensing Techniques; Drug Delivery Systems; Fever; Heating; Humans; Iron; Magnetic Resona

2008
Learning from history: understanding the carcinogenic risks of nanotechnology.
    Journal of the National Cancer Institute, 2008, Dec-03, Volume: 100, Issue:23

    Topics: Animals; Carcinogens; DNA Damage; Environmental Exposure; Humans; Inhalation Exposure; Nanoparticles

2008
A nanotube based electron microbeam cellular irradiator for radiobiology research.
    The Review of scientific instruments, 2008, Volume: 79, Issue:12

    Topics: Animals; Calibration; Electrons; Equipment Design; Fibroblasts; Film Dosimetry; Histones; Humans; Na

2008
Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells.
    Nano letters, 2009, Volume: 9, Issue:2

    Topics: Carrier Proteins; Cell Line, Tumor; ErbB Receptors; Folate Receptors, GPI-Anchored; Humans; Nanotube

2009
[Potential usefulness of carbon nanotubes for cancer therapy].
    Medecine sciences : M/S, 2009, Volume: 25, Issue:2

    Topics: Carbon; Graphite; Humans; Nanotubes, Carbon; Neoplasms

2009
Monte carlo simulation of an X-ray pixel beam microirradiation system.
    Radiation research, 2009, Volume: 171, Issue:3

    Topics: Animals; Electrodes; Feasibility Studies; Humans; Mice; Monte Carlo Method; Nanotubes, Carbon; Neopl

2009
Cancer-cell targeting and photoacoustic therapy using carbon nanotubes as "bomb" agents.
    Small (Weinheim an der Bergstrasse, Germany), 2009, Volume: 5, Issue:11

    Topics: Cell Line, Tumor; Flow Cytometry; Humans; Microscopy, Confocal; Nanotechnology; Nanotubes, Carbon; N

2009
Spongelike structures of hexa-peri-hexabenzocoronene derivatives enhance the sensitivity of chemiresistive carbon nanotubes to nonpolar volatile organic compounds of cancer.
    Langmuir : the ACS journal of surfaces and colloids, 2009, May-05, Volume: 25, Issue:9

    Topics: Calibration; Microscopy, Electron, Scanning; Molecular Structure; Nanotubes, Carbon; Neoplasms; Orga

2009
Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes.
    Nano letters, 2008, Volume: 8, Issue:12

    Topics: Chromatography, Gel; Drug Delivery Systems; Nanotubes, Carbon; Neoplasms; Nucleic Acid Hybridization

2008
Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems.
    Nanotechnology, 2009, Mar-25, Volume: 20, Issue:12

    Topics: Analysis of Variance; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dendrimers; Dose-Resp

2009
Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging.
    Biomacromolecules, 2009, Jul-13, Volume: 10, Issue:7

    Topics: Dendrimers; Diagnostic Imaging; Drug Delivery Systems; Humans; Nanotubes, Carbon; Neoplasms

2009
Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.
    Journal of the American Chemical Society, 2008, Dec-10, Volume: 130, Issue:49

    Topics: Biological Transport; Biotin; Cell Line; Drug Carriers; Drug Design; Endocytosis; Nanotubes, Carbon;

2008
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Multiwalled carbon nanotube buckypaper: toxicology and biological effects in vitro and in vivo.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Humans; Nanotubes, Carbon; Neoplasms; Rats

2009
Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes.
    Biomaterials, 2009, Volume: 30, Issue:30

    Topics: Biocompatible Materials; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Deli

2009
Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes.
    ACS nano, 2009, Sep-22, Volume: 3, Issue:9

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA; Feasibility Studies; Hot Temperatur

2009
Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy.
    Angewandte Chemie (International ed. in English), 2009, Volume: 48, Issue:41

    Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Doxorubicin; Drug Carriers; Humans; I

2009
Heating and cooling dynamics of carbon nanotubes observed by temperature-jump spectroscopy and electron microscopy.
    Journal of the American Chemical Society, 2009, Nov-11, Volume: 131, Issue:44

    Topics: Cell Death; Heating; Humans; Infrared Rays; Lasers; Microscopy, Electron, Transmission; Nanotubes, C

2009
In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes.
    ACS nano, 2009, Nov-24, Volume: 3, Issue:11

    Topics: Ablation Techniques; Animals; Cell Line, Tumor; Humans; Infrared Rays; Mice; Mice, Nude; Nanotubes,

2009
Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug.
    Nanomedicine (London, England), 2009, Volume: 4, Issue:8

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Etoposide; Flow Cytometry; HeLa Cells; Huma

2009
Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.
    Nanotechnology, 2010, Feb-10, Volume: 21, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carrier

2010
Subcutaneous injection of water-soluble multi-walled carbon nanotubes in tumor-bearing mice boosts the host immune activity.
    Nanotechnology, 2010, Apr-09, Volume: 21, Issue:14

    Topics: Animals; Cell Proliferation; Complement Activation; Complement C3; Cytokines; Immunity; Injections,

2010
Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies.
    Experimental oncology, 2010, Volume: 32, Issue:1

    Topics: Animals; Animals, Outbred Strains; Carcinoma, Ehrlich Tumor; Cell Death; Hyperthermia, Induced; Infr

2010
Carbon nanotube/hexa-peri-hexabenzocoronene bilayers for discrimination between nonpolar volatile organic compounds of cancer and humid atmospheres.
    Advanced materials (Deerfield Beach, Fla.), 2010, Oct-08, Volume: 22, Issue:38

    Topics: Biomarkers, Tumor; Electrodes; Humans; Nanotubes, Carbon; Neoplasms; Polycyclic Compounds; Principal

2010
Advances in platinum chemotherapeutics.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2010, Jun-25, Volume: 16, Issue:24

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Dendrimers; Drug Delivery Systems; Humans; Molecular

2010
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death.
    Nanotechnology, 2010, Aug-20, Volume: 21, Issue:33

    Topics: Apoptosis; Carboplatin; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Drug Deli

2010
Highly sensitive identification of cancer cells by combining the new tetrathiafulvalene derivative with a β-cyclodextrin/multi-walled carbon nanotubes modified GCE.
    The Analyst, 2010, Volume: 135, Issue:11

    Topics: beta-Cyclodextrins; Carbon; Cells, Cultured; Electrochemistry; Electrodes; Glass; Heterocyclic Compo

2010
Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors.
    Biomaterials, 2011, Volume: 32, Issue:1

    Topics: Ablation Techniques; Animals; Blood Circulation; Half-Life; Maleic Anhydrides; Mice; Mice, Inbred BA

2011
Lectin-based biosensor strategy for electrochemical assay of glycan expression on living cancer cells.
    Analytical chemistry, 2010, Nov-15, Volume: 82, Issue:22

    Topics: Biosensing Techniques; Cell Line, Tumor; Cell Survival; Concanavalin A; Electrochemistry; Electrodes

2010
Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes.
    Nanoscale, 2011, Volume: 3, Issue:2

    Topics: Antineoplastic Agents; Contrast Media; Fullerenes; Graphite; Humans; Nanoparticles; Nanotubes, Carbo

2011
Nanoparticles: heating tumors to death?
    Nanomedicine (London, England), 2011, Volume: 6, Issue:1

    Topics: Animals; Gold; Humans; Hyperthermia, Induced; Magnetics; Nanoparticles; Nanostructures; Nanotubes, C

2011
Single walled carbon nanohorns as photothermal cancer agents.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:1

    Topics: Animals; Combined Modality Therapy; Laser Therapy; Nanotubes, Carbon; Neoplasms; Tumor Cells, Cultur

2011
Nanosecond pulse electrical fields used in conjunction with multi-wall carbon nanotubes as a potential tumor treatment.
    Biomedical materials (Bristol, England), 2011, Volume: 6, Issue:1

    Topics: Animals; Biocompatible Materials; Cell Death; Cell Line, Tumor; Cell Survival; Electric Stimulation

2011
Nanotechnology under the skin.
    Nanotechnology, 2011, Jul-01, Volume: 22, Issue:26

    Topics: Animals; Humans; Nanotechnology; Nanotubes, Carbon; Neoplasms; RNA Interference; Skin; Zebrafish

2011
Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy.
    Small (Weinheim an der Bergstrasse, Germany), 2011, Oct-04, Volume: 7, Issue:19

    Topics: Animals; Cell Death; Cell Line, Tumor; Epithelial Cells; Female; Hyperthermia, Induced; Lasers; Mice

2011
Enhanced cell uptake via non-covalent decollation of a single-walled carbon nanotube-DNA hybrid with polyethylene glycol-grafted poly(l-lysine) labeled with an Alexa-dye and its efficient uptake in a cancer cell.
    Nanoscale, 2011, Oct-05, Volume: 3, Issue:10

    Topics: Cell Line, Tumor; DNA; Fluorescent Dyes; Humans; Microscopy, Atomic Force; Nanotubes, Carbon; Neopla

2011
Carbon nanotube-based ultrasensitive multiplexing electrochemical immunosensor for cancer biomarkers.
    Biosensors & bioelectronics, 2011, Dec-15, Volume: 30, Issue:1

    Topics: Biomarkers, Tumor; Biosensing Techniques; Complex Mixtures; Conductometry; Equipment Design; Equipme

2011
Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Division; Colonic Neoplasms; Cytokines; D

2011
Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer.
    Nanotechnology, 2011, Nov-11, Volume: 22, Issue:45

    Topics: Analysis of Variance; Cell Line, Tumor; Cell Survival; Drug Carriers; Endothelial Cells; Humans; Inf

2011
A label-free cytosensor for the enhanced electrochemical detection of cancer cells using polydopamine-coated carbon nanotubes.
    The Analyst, 2012, Mar-21, Volume: 137, Issue:6

    Topics: Animals; Biocompatible Materials; Biosensing Techniques; Cell Line, Tumor; Electrochemical Technique

2012
Preparation, characterization and cytotoxicity of carbon nanotube-chitosan-phycocyanin complex.
    Nanotechnology, 2012, Jan-27, Volume: 23, Issue:3

    Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chitosan; Humans; Nanotubes, Carbon; Neopl

2012
Paper-based three-dimensional electrochemical immunodevice based on multi-walled carbon nanotubes functionalized paper for sensitive point-of-care testing.
    Biosensors & bioelectronics, 2012, Feb-15, Volume: 32, Issue:1

    Topics: CA-125 Antigen; Carcinoembryonic Antigen; Electrochemical Techniques; Equipment Design; Humans; Immu

2012
Commentary on some recent theses relevant to combating aging: February 2012.
    Rejuvenation research, 2012, Volume: 15, Issue:1

    Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain Neoplasms; Drosophila melanogaster;

2012
Chinese medicine single-walled carbon nanotube targeting compound for antitumor therapy: a feasible way?
    Chinese journal of integrative medicine, 2014, Volume: 20, Issue:1

    Topics: Antineoplastic Agents; Cell Death; Drug Carriers; Drug Delivery Systems; Drugs, Chinese Herbal; Feas

2014
Mitochondria-targeting photoacoustic therapy using single-walled carbon nanotubes.
    Small (Weinheim an der Bergstrasse, Germany), 2012, May-21, Volume: 8, Issue:10

    Topics: Animals; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Female; Mice; Mice, Inbred BALB C; Mit

2012
Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy.
    Journal of the American Chemical Society, 2012, May-02, Volume: 134, Issue:17

    Topics: Cell Line, Tumor; DNA; Gold; Humans; Nanocomposites; Nanotubes, Carbon; Neoplasms; Phototherapy; Sil

2012
Carbon nanospheres-promoted electrochemical immunoassay coupled with hollow platinum nanolabels for sensitivity enhancement.
    Biosensors & bioelectronics, 2012, May-15, Volume: 35, Issue:1

    Topics: Biosensing Techniques; Carcinoembryonic Antigen; Electrochemical Techniques; Graphite; Horseradish P

2012
Nanoparticle-mediated hyperthermia in cancer therapy.
    Therapeutic delivery, 2011, Volume: 2, Issue:8

    Topics: Ferric Compounds; Gold; Graphite; Humans; Hyperthermia, Induced; Metal Nanoparticles; Nanotubes, Car

2011
Polydiacetylene single-walled carbon nanotubes nano-hybrid for cellular imaging applications.
    Journal of nanoscience and nanotechnology, 2012, Volume: 12, Issue:1

    Topics: Cell Line, Tumor; Contrast Media; Humans; Microscopy; Nanotubes, Carbon; Neoplasms; Polyacetylene Po

2012
Carbon nanotube exploration in cancer cell lines.
    Drug discovery today, 2012, Volume: 17, Issue:17-18

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Humans; Nanotubes, Carbon; Neoplasm

2012
Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment.
    Journal of biomedical nanotechnology, 2012, Volume: 8, Issue:4

    Topics: Cell Survival; Drug Delivery Systems; Gene Silencing; Hep G2 Cells; Humans; Nanotubes, Carbon; Neopl

2012
Monte Carlo simulation of a compact microbeam radiotherapy system based on carbon nanotube field emission technology.
    Medical physics, 2012, Volume: 39, Issue:8

    Topics: Animals; Computer Simulation; Electrodes; Equipment Design; Humans; Monte Carlo Method; Nanotechnolo

2012
Sensitive immunosensor for the label-free determination of tumor marker based on carbon nanotubes/mesoporous silica and graphene modified electrode.
    Biosensors & bioelectronics, 2013, Mar-15, Volume: 41

    Topics: alpha-Fetoproteins; Biomarkers, Tumor; Biosensing Techniques; Conductometry; Equipment Design; Equip

2013
Chirality enriched (12,1) and (11,3) single-walled carbon nanotubes for biological imaging.
    Journal of the American Chemical Society, 2012, Oct-17, Volume: 134, Issue:41

    Topics: Animals; Luminescence; Mice; Mice, Nude; Nanotubes, Carbon; Neoplasms; Optical Imaging; Semiconducto

2012
Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
    Bioconjugate chemistry, 2012, Nov-21, Volume: 23, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carbocyanines; Cell Line, Tumor; Cell Proliferation; Dose

2012
Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes.
    Biomaterials, 2013, Volume: 34, Issue:1

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Drug Delivery System

2013
Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery.
    Langmuir : the ACS journal of surfaces and colloids, 2012, Nov-27, Volume: 28, Issue:47

    Topics: Biological Transport; Doxorubicin; Drug Carriers; Fluorescent Dyes; HEK293 Cells; HeLa Cells; Humans

2012
Evaluation of the shear force of single cancer cells by vertically aligned carbon nanotubes suitable for metastasis diagnosis.
    Integrative biology : quantitative biosciences from nano to macro, 2013, Volume: 5, Issue:3

    Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Colonic Neoplasms; Cytoskeleton; Humans; Microscopy, Electr

2013
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-16, Volume: 102, Issue:33

    Topics: Cell Death; Cell Survival; Drug Delivery Systems; HeLa Cells; Humans; Infrared Rays; Lasers; Ligands

2005
Nanotechnology used to kill tumour cells.
    The Lancet. Oncology, 2005, Volume: 6, Issue:9

    Topics: Humans; Nanotubes, Carbon; Neoplasms; Phototherapy

2005
Detection of tumor markers using single-walled carbon nanotube field effect transistors.
    Journal of nanoscience and nanotechnology, 2006, Volume: 6, Issue:11

    Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Biosensing Techniques; Carcinoembryonic Antigen;

2006
Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:7

    Topics: Antibodies; Cell Membrane Permeability; Chelating Agents; Drug Delivery Systems; Heterocyclic Compou

2007
Magnetic lymphatic targeting drug delivery system using carbon nanotubes.
    Medical hypotheses, 2008, Volume: 70, Issue:4

    Topics: Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Lymph Nodes; Lymphatic System; Magnetics;

2008
Thermal ablation therapeutics based on CN(x) multi-walled nanotubes.
    International journal of nanomedicine, 2007, Volume: 2, Issue:4

    Topics: Cell Line, Tumor; Cell Survival; Humans; Hyperthermia, Induced; Infrared Rays; Nanomedicine; Nanotub

2007
Study and numerical analysis of Von Mises stress of a new tumor-type distal femoral prosthesis comprising a peek composite reinforced with carbon fibers: finite element analysis.
    Computer methods in biomechanics and biomedical engineering, 2022, Volume: 25, Issue:15

    Topics: Carbon Fiber; Femur; Finite Element Analysis; Humans; Joint Prosthesis; Ketones; Neoplasms; Polyethy

2022
Clinical evaluation of vertebral body replacement of carbon fiber-reinforced polyetheretherketone in patients with tumor manifestation of the thoracic and lumbar spine.
    Acta neurochirurgica, 2023, Volume: 165, Issue:4

    Topics: Carbon Fiber; Humans; Ketones; Lumbar Vertebrae; Neoplasms; Polyethylene Glycols; Retrospective Stud

2023
Dosimetric characterization of carbon fiber stabilization devices for post-operative particle therapy.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2017, Volume: 44

    Topics: Benzophenones; Carbon; Carbon Fiber; Heavy Ion Radiotherapy; Humans; Ketones; Neoplasms; Polyethylen

2017
Modeling of couch transmission in the RayStation treatment planning system.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2016, Volume: 32, Issue:5

    Topics: Carbon; Carbon Fiber; Humans; Male; Models, Statistical; Neoplasms; Phantoms, Imaging; Prostatic Neo

2016
Carbon fiber couches and skin sparing.
    Journal of applied clinical medical physics, 2010, Apr-16, Volume: 11, Issue:2

    Topics: Anti-Infective Agents, Local; Carbon; Carbon Fiber; Humans; Neoplasms; Patient Positioning; Prosthes

2010
A validation of carbon fiber imaging couch top modeling in two radiation therapy treatment planning systems: Philips Pinnacle3 and BrainLAB iPlan RT Dose.
    Radiation oncology (London, England), 2012, Nov-09, Volume: 7

    Topics: Carbon; Carbon Fiber; Humans; Image Processing, Computer-Assisted; Neoplasms; Phantoms, Imaging; Rad

2012